| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.79e-06 | 14 | 319 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 RASGRP4 DCHS2 ENPP1 CDH23 ADGRV1 SVEP1 RYR1 RYR2 RYR3 ITPR2 FAT1 FBN2 EEF2K BAIAP3 HSPA5 PCDH18 FAT4 EFCAB6 PCDHGA4 PCDHGA1 PCDHA1 CUBN TGM2 PPP2R3A CADPS PRF1 LRP2 MACF1 PLCH1 | 3.97e-06 | 749 | 319 | 30 | GO:0005509 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.28e-06 | 18 | 319 | 5 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.60e-05 | 4 | 319 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.68e-05 | 23 | 319 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 7.80e-05 | 6 | 319 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 8.74e-05 | 29 | 319 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | filamin binding | 8.74e-05 | 29 | 319 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.22e-04 | 31 | 319 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.24e-04 | 49 | 319 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.56e-04 | 51 | 319 | 6 | GO:0043394 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | POGLUT3 DPY19L3 GALNT1 GCNT3 MGAT5 OGT B3GALNT2 UGT1A4 DPY19L4 POFUT1 WDFY3 PIGM | 1.57e-04 | 211 | 319 | 12 | GO:0016758 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.66e-04 | 33 | 319 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.92e-04 | 34 | 319 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | calmodulin binding | ARPP21 PSG1 PSG2 PSG3 PSG5 PSG11 RYR1 RYR2 RYR3 KCNN3 EEF2K SNTB2 | 3.46e-04 | 230 | 319 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | KDEL sequence binding | 7.55e-04 | 3 | 319 | 2 | GO:0005046 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | ST6GALNAC1 POGLUT3 DPY19L3 GALNT1 GCNT3 MGAT5 OGT B3GALNT2 UGT1A4 DPY19L4 POFUT1 WDFY3 PIGM | 7.85e-04 | 288 | 319 | 13 | GO:0016757 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 8.81e-04 | 70 | 319 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.03e-03 | 13 | 319 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.10e-03 | 73 | 319 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.11e-03 | 129 | 319 | 8 | GO:0005262 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | PSG1 PSG2 PSG3 PSG5 PSG11 STAT3 LRIG2 PTPRS HRG CLASP1 MUC16 SLC12A2 TNR | 6.74e-08 | 126 | 314 | 13 | GO:1903035 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.84e-07 | 20 | 314 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | tissue remodeling | TRAF6 PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 DOCK5 HRG GPNMB TMEM64 KLF6 SLC4A2 TGM2 CSF1R RBPJ CELA1 | 6.11e-07 | 262 | 314 | 17 | GO:0048771 |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | TRAF6 ABCA4 PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 CDH23 ADGRV1 IFT80 TMEM64 XIAP CUBN SLC4A2 CSF1R SLC12A2 STRAP VPS13B | 9.88e-07 | 334 | 314 | 19 | GO:0060249 |
| GeneOntologyBiologicalProcess | tissue homeostasis | TRAF6 ABCA4 PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 CDH23 ADGRV1 IFT80 TMEM64 XIAP CUBN SLC4A2 CSF1R SLC12A2 STRAP VPS13B | 9.88e-07 | 334 | 314 | 19 | GO:0001894 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PRTG PSG1 PSG2 PSG3 PSG5 PSG11 CDH23 FAT1 PCDH18 FAT4 PCDHGA4 PCDHGA1 PCDHA1 | 1.13e-06 | 187 | 314 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.42e-06 | 14 | 314 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PRTG PSG1 PSG2 PSG3 PSG5 PSG11 CDH23 ITGA3 FAT1 PTPRS PCDH18 FAT4 PCDHGA4 PCDHGA1 PCDHA1 CLDN16 TENM1 | 1.64e-06 | 313 | 314 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of cell size | ADCY10 ILK CYFIP1 CLCN6 PTPRS OGT DEPTOR FN1 SEMA5A SLC12A2 ABCB8 PLXNA4 MACF1 TNR EPHA7 | 2.02e-06 | 225 | 314 | 15 | GO:0008361 |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 2.10e-06 | 15 | 314 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.10e-06 | 15 | 314 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.10e-06 | 15 | 314 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 2.10e-06 | 15 | 314 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | bone resorption | 2.73e-06 | 99 | 314 | 10 | GO:0045453 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 3.01e-06 | 16 | 314 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | bone remodeling | TRAF6 PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 DOCK5 TMEM64 SLC4A2 CSF1R | 3.96e-06 | 127 | 314 | 11 | GO:0046849 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 4.22e-06 | 17 | 314 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 4.22e-06 | 17 | 314 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 4.22e-06 | 17 | 314 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | PSG1 PSG2 PSG3 PSG5 PSG11 HRG GPNMB TMEM64 KLF6 SLC4A2 CSF1R | 4.28e-06 | 128 | 314 | 11 | GO:0034103 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | IFT140 INTU TRAF6 PDE6C ILK GCNT3 RNLS PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 SPEF2 CDH23 PTCH1 PDCD4 FREM1 RYR1 RYR2 STAT3 FAT1 FBN2 SEC24B PTPRQ PKHD1 FGFR1 IFT80 COL5A1 FAT4 TECTA TFAP2C SLC4A2 TGM2 PPP2R3A CSF1R SLC12A2 RBPJ LRP2 CELA1 FBXW7 | 4.31e-06 | 1269 | 314 | 41 | GO:0009887 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB3 DOK5 ILK PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 BLNK ITGA3 ERBIN PDCD4 SVEP1 RYR1 STAT3 LRIG2 CYFIP1 FBN2 PIK3C2A HRG FGFR1 IFT80 HSPA5 SH3TC2 FAT4 OGT GPER1 KALRN XIAP CSF1R SAMD10 STRAP RBPJ LRP2 ROS1 SMAD1 SMAD5 EPHA7 | 5.01e-06 | 1186 | 314 | 39 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of cell growth | ADCY10 ILK PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 RPS6KA3 PHB1 CYFIP1 SBF1 PTPRS HRG PLAAT1 FN1 NEDD4L SEMA5A PLXNA4 MACF1 ROS1 TNR EPHA7 | 5.22e-06 | 519 | 314 | 23 | GO:0001558 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 5.77e-06 | 18 | 314 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | ILK PSG1 PSG2 PSG3 PSG5 PSG11 STAT3 PHB1 PIK3C2A PKHD1 FGFR1 IFT80 FN1 GPER1 SEMA5A CSF1R LINGO1 CNTNAP2 LRP2 | 7.01e-06 | 382 | 314 | 19 | GO:0043491 |
| GeneOntologyBiologicalProcess | osteoclast differentiation | TRAF6 PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 IFT80 TMEM64 SLC4A2 CSF1R FBXW7 | 7.37e-06 | 162 | 314 | 12 | GO:0030316 |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 7.70e-06 | 32 | 314 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of growth | ADCY10 ILK ACACB PSG1 PSG2 CACNA2D2 PSG3 PSG5 ENPP1 PSG11 RPS6KA3 PTCH1 STAT3 PHB1 CYFIP1 SBF1 PTPRS HRG FGFR1 PLAAT1 FN1 NEDD4L SEMA5A RBPJ PLXNA4 MACF1 ROS1 TNR EPHA7 | 8.88e-06 | 777 | 314 | 29 | GO:0040008 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | EPHB3 ADCY10 ILK PSG1 PSG2 PSG3 PSG5 PSG11 PGAM5 STAT3 CYFIP1 PTPRS SEC24B MKLN1 PKHD1 HRG EEF2K FGFR1 GPNMB FN1 NEDD4L CLASP1 KALRN SYNE1 SEMA5A TGM2 CSF1R SLC12A2 RBPJ PLXNA4 CELA1 MACF1 TNR ZMYM6 SMAD1 EPHA7 | 1.09e-05 | 1090 | 314 | 36 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.10e-05 | 70 | 314 | 8 | GO:0045124 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB3 DOK5 PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 BLNK ERBIN SVEP1 STAT3 LRIG2 CYFIP1 PIK3C2A HRG FGFR1 IFT80 SH3TC2 FAT4 OGT GPER1 KALRN CSF1R SAMD10 RBPJ ROS1 EPHA7 | 1.18e-05 | 747 | 314 | 28 | GO:0007169 |
| GeneOntologyBiologicalProcess | growth | ADCY10 ILK ACACB PSG1 PSG2 CACNA2D2 PSG3 PSG5 ENPP1 PSG11 RPS6KA3 PTCH1 STAT3 PHB1 KMT2C CYFIP1 SBF1 PTPRS HRG FGFR1 IFT80 PLAAT1 FN1 NEDD4L SEMA5A TFAP2C PPP2R3A CSF1R SLC12A2 RBPJ CNTNAP2 PLXNA4 CELA1 MACF1 ROS1 TNR VPS13B SMAD1 EPHA7 | 1.28e-05 | 1235 | 314 | 39 | GO:0040007 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.32e-05 | 21 | 314 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.32e-05 | 21 | 314 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.32e-05 | 21 | 314 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.33e-05 | 35 | 314 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 1.50e-05 | 73 | 314 | 8 | GO:0060119 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.59e-05 | 96 | 314 | 9 | GO:0060113 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.69e-05 | 22 | 314 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.77e-05 | 122 | 314 | 10 | GO:0061387 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 1.88e-05 | 98 | 314 | 9 | GO:0061045 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | PSG1 PSG2 PSG3 PSG5 PSG11 PTCH1 FGFR1 TFAP2C TGM2 CSF1R SLC12A2 FBXW7 | 1.91e-05 | 178 | 314 | 12 | GO:0022612 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.13e-05 | 23 | 314 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.13e-05 | 23 | 314 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.17e-05 | 56 | 314 | 7 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.17e-05 | 38 | 314 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.65e-05 | 24 | 314 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.65e-05 | 24 | 314 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.65e-05 | 24 | 314 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | epithelium development | IFT140 INTU TRAF6 ILK PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 CDH23 PTCH1 RYR2 FAT1 PTPRS SEC24B PTPRQ PKHD1 FGFR1 IFT80 RHCG COL5A1 FAT4 PLAAT1 CLASP1 CECR2 SEMA5A TECTA TFAP2C TGM2 PPP2R3A CSF1R SLC12A2 KLF7 RBPJ PLXNA4 LRP2 ROS1 POFUT1 HYDIN SMAD1 SMAD5 EPHA7 | 2.78e-05 | 1469 | 314 | 43 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 2.96e-05 | 80 | 314 | 8 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | PSG1 PSG2 PSG3 PSG5 PSG11 STAT3 LRIG2 PTPRS HRG CLASP1 MUC16 SLC12A2 TNR | 3.02e-05 | 217 | 314 | 13 | GO:1903034 |
| GeneOntologyBiologicalProcess | regulation of axon extension | 3.03e-05 | 104 | 314 | 9 | GO:0030516 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 3.03e-05 | 104 | 314 | 9 | GO:0042490 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 3.28e-05 | 25 | 314 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 3.28e-05 | 25 | 314 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | cell growth | ADCY10 ILK PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 RPS6KA3 PHB1 CYFIP1 SBF1 PTPRS HRG PLAAT1 FN1 NEDD4L SEMA5A CSF1R PLXNA4 MACF1 ROS1 TNR EPHA7 | 3.45e-05 | 625 | 314 | 24 | GO:0016049 |
| GeneOntologyBiologicalProcess | MAPK cascade | DOK5 TRAF6 ILK PSG1 PSG2 PSG3 PSG5 NEK10 PSG11 PDCD4 PHB1 PKHD1 FGFR1 GPNMB FN1 GPER1 MAP3K8 MAP3K14 XIAP MBIP ACE2 CSF1R DUSP16 CNTNAP2 TENM1 ROS1 MAPK4 SMAD1 EPHA7 GRAP FBXW7 | 3.88e-05 | 930 | 314 | 31 | GO:0000165 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 DCHS2 PRTG TRAF6 ILK PSG1 PSG2 PSG3 PSG5 PSG11 CDH23 NCAM2 ADGRV1 ITGA3 IL1RL2 SVEP1 FAT1 PTPRS PKHD1 GPNMB PCDH18 FAT4 ZAN MAP3K8 PCDHGA4 PCDHGA1 PCDHA1 CD200R1 SLC4A2 CD80 CLDN16 TENM1 TNR EPHA7 | 4.82e-05 | 1077 | 314 | 34 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.86e-05 | 27 | 314 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 ADCY10 IFT140 PRTG PDE6C ILK ENPP1 CDH23 NCAM2 ADGRV1 ITGA3 PTCH1 CSMD3 LRIG2 CYFIP1 PTPRS SEC24B PTPRQ EEF2K FGFR1 HSPA5 FAT4 FN1 NEDD4L KALRN SYNE1 CECR2 SEMA5A FRYL TECTA CSF1R LINGO1 KLF7 CLMN CNTNAP2 PLXNA4 TENM1 LRP2 MACF1 TNR VPS13B EPHA7 | 5.43e-05 | 1463 | 314 | 42 | GO:0048666 |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 5.43e-05 | 87 | 314 | 8 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.84e-05 | 28 | 314 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | ADCY10 ILK CYFIP1 PTPRS FN1 NEDD4L SEMA5A TFAP2C PPP2R3A CSF1R SLC12A2 PLXNA4 MACF1 TNR EPHA7 | 5.91e-05 | 299 | 314 | 15 | GO:0060560 |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 6.40e-05 | 66 | 314 | 7 | GO:0010543 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 6.66e-05 | 46 | 314 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 6.66e-05 | 46 | 314 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 ADCY10 PRTG ILK ENPP1 CDH23 NCAM2 ADGRV1 ITGA3 PTCH1 CSMD3 LRIG2 CYFIP1 PTPRS SEC24B EEF2K FGFR1 HSPA5 FAT4 FN1 NEDD4L KALRN SYNE1 CECR2 SEMA5A FRYL TECTA CSF1R LINGO1 KLF7 CLMN CNTNAP2 PLXNA4 LRP2 MACF1 TNR VPS13B EPHA7 | 6.87e-05 | 1285 | 314 | 38 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 6.97e-05 | 29 | 314 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 7.18e-05 | 116 | 314 | 9 | GO:0045670 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 8.75e-05 | 93 | 314 | 8 | GO:1901184 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 9.57e-05 | 49 | 314 | 6 | GO:0002837 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 9.57e-05 | 49 | 314 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 9.72e-05 | 31 | 314 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.02e-04 | 71 | 314 | 7 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.07e-04 | 50 | 314 | 6 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.12e-04 | 72 | 314 | 7 | GO:0032692 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | EPHB3 TRAF6 ILK PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 PTCH1 RYR2 STAT3 PIK3C2A SEC24B PKHD1 HRG FGFR1 GPNMB FAT4 FN1 CECR2 SEMA5A TFAP2C TGM2 CSF1R SLC12A2 RBPJ LRP2 CELA1 POFUT1 SMAD1 SMAD5 EPHA7 FBXW7 | 1.12e-04 | 1125 | 314 | 34 | GO:0035239 |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.14e-04 | 32 | 314 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.14e-04 | 32 | 314 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | A2M PSG1 PSG2 PSG3 PSG5 PSG11 MEFV STAT3 LRIG2 PTPRS HRG MMP26 CLASP1 GPER1 MUC16 SEMA5A CD200R1 SLC12A2 CNTNAP2 TNR | 1.15e-04 | 509 | 314 | 20 | GO:0032102 |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.32e-04 | 33 | 314 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.32e-04 | 33 | 314 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 1.49e-04 | 53 | 314 | 6 | GO:0060122 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.53e-04 | 34 | 314 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.53e-04 | 34 | 314 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 1.62e-04 | 129 | 314 | 9 | GO:0043406 | |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB3 IFT140 ILK RNLS ACACB PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 ITGA3 PTCH1 PDCD4 SVEP1 RYR1 RYR2 STAT3 PIK3C2A SEC24B HRG FGFR1 GPNMB COL5A1 FAT4 FN1 GPER1 SYNE1 SEMA5A TGM2 SLC12A2 DAW1 RBPJ PLXNA4 LRP2 CELA1 POFUT1 SMAD1 SMAD5 FBXW7 | 1.72e-04 | 1442 | 314 | 40 | GO:0072359 |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.76e-04 | 160 | 314 | 10 | GO:0038127 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | EPHB3 ADCY10 ILK CYFIP1 PTPRS FN1 SEMA5A PLXNA4 MACF1 TNR EPHA7 | 1.82e-04 | 192 | 314 | 11 | GO:0050770 |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 1.84e-04 | 55 | 314 | 6 | GO:0045773 | |
| GeneOntologyBiologicalProcess | tube development | EPHB3 IFT140 INTU TRAF6 ILK PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 ITGA3 PTCH1 RYR2 STAT3 PIK3C2A SEC24B PKHD1 HRG FGFR1 GPNMB FAT4 FN1 CECR2 SEMA5A TFAP2C SLC4A2 TGM2 CSF1R SLC12A2 RBPJ PLXNA4 LRP2 CELA1 POFUT1 SMAD1 SMAD5 EPHA7 FBXW7 | 1.97e-04 | 1402 | 314 | 39 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | ILK PSG1 PSG2 PSG3 PSG5 PSG11 PHB1 PKHD1 FGFR1 FN1 GPER1 SEMA5A CSF1R LINGO1 CNTNAP2 | 2.01e-04 | 334 | 314 | 15 | GO:0051896 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 ADCY10 PRTG ILK CDH23 PTCH1 CYFIP1 PTPRS SEC24B PTPRQ EEF2K FN1 NEDD4L KALRN SYNE1 SEMA5A TECTA CSF1R KLF7 CNTNAP2 PLXNA4 LRP2 MACF1 TNR EPHA7 | 2.13e-04 | 748 | 314 | 25 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | ADCY10 ILK SVEP1 DOCK5 CYFIP1 CLCN6 PIK3C2A PTPRS OGT DEPTOR FN1 GPER1 SEMA5A ACE2 SLC12A2 ABCB8 PLXNA4 TENM1 MACF1 CAPZA3 TNR EPHA7 | 2.16e-04 | 618 | 314 | 22 | GO:0090066 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | INTU TRAF6 ILK ENPP1 PTCH1 RYR2 FAT1 SEC24B PKHD1 FGFR1 COL5A1 FAT4 CLASP1 CECR2 SEMA5A TFAP2C TGM2 CSF1R SLC12A2 RBPJ LRP2 EPHA7 | 2.21e-04 | 619 | 314 | 22 | GO:0002009 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | INTU TRAF6 ILK GCNT3 ENPP1 PTCH1 RYR2 FAT1 SEC24B PKHD1 FGFR1 COL5A1 FAT4 CLASP1 CECR2 SEMA5A TFAP2C TGM2 CSF1R SLC12A2 RBPJ LRP2 MACF1 SMAD1 EPHA7 | 2.22e-04 | 750 | 314 | 25 | GO:0048729 |
| GeneOntologyBiologicalProcess | axon extension | 2.29e-04 | 135 | 314 | 9 | GO:0048675 | |
| GeneOntologyBiologicalProcess | endocytic hemoglobin import into cell | 2.31e-04 | 2 | 314 | 2 | GO:0020028 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 2.33e-04 | 107 | 314 | 8 | GO:0042130 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 3.05e-06 | 16 | 319 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 8.38e-05 | 16 | 319 | 4 | GO:0030127 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.24e-04 | 73 | 319 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ADCY10 TRAF6 GALNT1 TSNAX ADGRV1 ITGA3 PTCH1 RYR1 RYR3 FAT1 CYFIP1 SBF1 OSBPL7 PKHD1 FGFR1 SEC23A GPER1 KALRN SYNE1 XIAP COPS3 TG TGM2 IGHMBP2 TENM1 DGKI ROS1 STX16 FBXW7 | 2.45e-04 | 934 | 319 | 29 | GO:0048471 |
| GeneOntologyCellularComponent | cilium | ADCY10 IFT140 INTU CFAP251 CATSPERE ABCA4 DCDC2C PSG1 PSG2 PSG3 PSG5 PSG11 SPEF2 CDH23 ADGRV1 PTCH1 CC2D2B SAG CT55 PKHD1 IFT80 EVC2 EFCAB6 ALPK1 ACE2 DAW1 CCT8 HYDIN | 2.93e-04 | 898 | 319 | 28 | GO:0005929 |
| GeneOntologyCellularComponent | lateral plasma membrane | 4.57e-04 | 90 | 319 | 7 | GO:0016328 | |
| GeneOntologyCellularComponent | extracellular matrix | A2M ERBIN SVEP1 FREM1 LRIG2 TINAG FBN2 ADAMTS17 HRG GPC5 PZP MMP26 COL5A1 ZAN FN1 TECTA FCN3 TGM2 LINGO1 SMC3 CELA1 TNR | 5.05e-04 | 656 | 319 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M ERBIN SVEP1 FREM1 LRIG2 TINAG FBN2 ADAMTS17 HRG GPC5 PZP MMP26 COL5A1 ZAN FN1 TECTA FCN3 TGM2 LINGO1 SMC3 CELA1 TNR | 5.26e-04 | 658 | 319 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | extrinsic component of presynaptic active zone membrane | 6.89e-04 | 3 | 319 | 2 | GO:0098891 | |
| GeneOntologyCellularComponent | basal part of cell | ADCY10 PSG1 PSG2 PSG3 PSG5 ENPP1 PSG11 TRPC4 ITGA3 ERBIN PTPRQ RHCG CLASP1 SLC4A2 SLC12A2 | 7.54e-04 | 378 | 319 | 15 | GO:0045178 |
| GeneOntologyCellularComponent | ciliary membrane | 7.62e-04 | 98 | 319 | 7 | GO:0060170 | |
| GeneOntologyCellularComponent | apical part of cell | ADCY10 PSG1 PSG2 PSG3 PSG5 PSG11 CDH23 PTCH1 FAT1 PTPRQ PKHD1 C1QTNF5 RHCG FAT4 FN1 CUBN SLC4A2 ACE2 SLC12A2 LRP2 | 8.24e-04 | 592 | 319 | 20 | GO:0045177 |
| GeneOntologyCellularComponent | extrinsic component of membrane | TRAF6 CDH23 RYR1 RYR2 PHB1 PIK3C2A KALRN COQ5 CUBN CADPS DGKI | 8.56e-04 | 230 | 319 | 11 | GO:0019898 |
| GeneOntologyCellularComponent | side of membrane | RASGRP4 TRAF6 PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 ITGA3 RYR1 RYR2 RYR3 VNN2 PKHD1 GPC5 RASA3 MUC16 CUBN TECTA FCN3 CD200R1 CD1C THADA SAMD10 CD80 LRP2 | 9.76e-04 | 875 | 319 | 26 | GO:0098552 |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG2 PSG3 PSG5 PSG11 ADGRV1 ITGA3 PTCH1 EVC2 GPER1 CUBN ACE2 SLC12A2 CNTNAP2 LRP2 MACF1 | 1.03e-03 | 431 | 319 | 16 | GO:0031253 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.23e-03 | 78 | 319 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | apical plasma membrane | ADCY10 PSG1 PSG2 PSG3 PSG5 PSG11 FAT1 PTPRQ PKHD1 C1QTNF5 RHCG FN1 CUBN SLC4A2 ACE2 SLC12A2 LRP2 | 1.41e-03 | 487 | 319 | 17 | GO:0016324 |
| MousePheno | decreased susceptibility to Coronaviridae infection | 9.34e-06 | 28 | 255 | 6 | MP:0020950 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.00e-05 | 17 | 255 | 5 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.11e-05 | 21 | 255 | 5 | MP:0031415 | |
| MousePheno | abnormal orientation of cochlear hair cell stereociliary bundles | 3.62e-05 | 35 | 255 | 6 | MP:0004522 | |
| MousePheno | abnormal orientation of inner hair cell stereociliary bundles | 4.77e-05 | 12 | 255 | 4 | MP:0004492 | |
| MousePheno | decreased fatty acid oxidation | 6.21e-05 | 24 | 255 | 5 | MP:0014172 | |
| Domain | Ryanodine_recept-rel | 1.16e-06 | 6 | 315 | 4 | IPR015925 | |
| Domain | - | 1.16e-06 | 6 | 315 | 4 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 1.16e-06 | 6 | 315 | 4 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.16e-06 | 6 | 315 | 4 | PF08709 | |
| Domain | RIH_assoc | 1.16e-06 | 6 | 315 | 4 | PF08454 | |
| Domain | RIH_dom | 1.16e-06 | 6 | 315 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.16e-06 | 6 | 315 | 4 | IPR014821 | |
| Domain | RYDR_ITPR | 1.16e-06 | 6 | 315 | 4 | PF01365 | |
| Domain | - | EPHB3 PRTG POGLUT3 PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 FNDC1 IL1R2 PTPRS PKHD1 FGFR1 FN1 KALRN CD200R1 TGM2 CD1C CSF1R LINGO1 CD80 RBPJ PLXNA4 ROS1 TNR EPHA7 | 2.95e-06 | 663 | 315 | 29 | 2.60.40.10 |
| Domain | Ig-like_fold | EPHB3 PRTG POGLUT3 PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 FNDC1 IL1R2 PTPRS PKHD1 FGFR1 FN1 KALRN CD200R1 SLC4A2 TGM2 CD1C CSF1R LINGO1 CD80 RBPJ PLXNA4 ROS1 TNR EPHA7 | 3.53e-06 | 706 | 315 | 30 | IPR013783 |
| Domain | RyR | 4.75e-06 | 3 | 315 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 4.75e-06 | 3 | 315 | 3 | PF06459 | |
| Domain | Ryan_recept | 4.75e-06 | 3 | 315 | 3 | IPR013333 | |
| Domain | Ryanodine_rcpt | 4.75e-06 | 3 | 315 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.75e-06 | 3 | 315 | 3 | IPR009460 | |
| Domain | MIR | 1.54e-05 | 10 | 315 | 4 | PF02815 | |
| Domain | MIR_motif | 1.54e-05 | 10 | 315 | 4 | IPR016093 | |
| Domain | MIR | 1.54e-05 | 10 | 315 | 4 | PS50919 | |
| Domain | MIR | 1.54e-05 | 10 | 315 | 4 | SM00472 | |
| Domain | ARM-type_fold | USP34 NEK10 MROH5 PDCD4 RYR3 ITPR2 DOCK5 XPO5 PIK3C2A ARMH3 CLASP1 XPO4 FRYL RALGAPA2 THADA PPP2R5E WDFY3 TNPO3 | 1.97e-05 | 339 | 315 | 18 | IPR016024 |
| Domain | ConA-like_dom | ADGRV1 MEFV SVEP1 RYR1 RYR2 RYR3 MEP1A FAT1 SEL1L3 COL5A1 FAT4 ZAN CNTNAP2 WDFY3 | 2.23e-05 | 219 | 315 | 14 | IPR013320 |
| Domain | Ephrin_rec_like | 2.39e-05 | 11 | 315 | 4 | PF07699 | |
| Domain | IGc2 | PRTG PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 LRIG2 IL1R2 PTPRS FGFR1 KALRN CSF1R LINGO1 | 4.84e-05 | 235 | 315 | 14 | SM00408 |
| Domain | Ig_sub2 | PRTG PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 LRIG2 IL1R2 PTPRS FGFR1 KALRN CSF1R LINGO1 | 4.84e-05 | 235 | 315 | 14 | IPR003598 |
| Domain | Ig_E-set | 6.65e-05 | 104 | 315 | 9 | IPR014756 | |
| Domain | Sec23_24_beta_S | 9.15e-05 | 6 | 315 | 3 | IPR012990 | |
| Domain | Sec23/24_helical_dom | 9.15e-05 | 6 | 315 | 3 | IPR006900 | |
| Domain | zf-Sec23_Sec24 | 9.15e-05 | 6 | 315 | 3 | PF04810 | |
| Domain | Sec23_trunk | 9.15e-05 | 6 | 315 | 3 | PF04811 | |
| Domain | Sec23_helical | 9.15e-05 | 6 | 315 | 3 | PF04815 | |
| Domain | Sec23_BS | 9.15e-05 | 6 | 315 | 3 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 9.15e-05 | 6 | 315 | 3 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 9.15e-05 | 6 | 315 | 3 | IPR006895 | |
| Domain | ig | PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 IL1R2 PTPRS FGFR1 CSF1R | 9.61e-05 | 190 | 315 | 12 | PF00047 |
| Domain | Immunoglobulin | PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 IL1R2 PTPRS FGFR1 CSF1R | 9.61e-05 | 190 | 315 | 12 | IPR013151 |
| Domain | EGF-like_CS | SVEP1 MEP1A FAT1 FBN2 FAT4 ZAN FN1 CUBN PRF1 CNTNAP2 TENM1 LRP2 TNR EPHA7 | 1.48e-04 | 261 | 315 | 14 | IPR013032 |
| Domain | Cadherin | 1.76e-04 | 118 | 315 | 9 | IPR002126 | |
| Domain | - | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 SEMA5A STRAP DCAF10 DAW1 KCTD3 PLXNA4 SMU1 CSTF1 WDFY3 FBXW7 | 1.82e-04 | 333 | 315 | 16 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 SEMA5A STRAP DCAF10 DAW1 KCTD3 PLXNA4 SMU1 CSTF1 WDFY3 FBXW7 | 1.94e-04 | 335 | 315 | 16 | IPR015943 |
| Domain | WD40 | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 KCTD3 SMU1 CSTF1 WDFY3 FBXW7 | 1.95e-04 | 268 | 315 | 14 | SM00320 |
| Domain | WD40_repeat | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 KCTD3 SMU1 CSTF1 WDFY3 FBXW7 | 2.27e-04 | 272 | 315 | 14 | IPR001680 |
| Domain | - | 2.48e-04 | 74 | 315 | 7 | 3.40.50.410 | |
| Domain | WD_REPEATS_1 | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 KCTD3 SMU1 CSTF1 WDFY3 FBXW7 | 2.84e-04 | 278 | 315 | 14 | PS00678 |
| Domain | WD_REPEATS_2 | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 KCTD3 SMU1 CSTF1 WDFY3 FBXW7 | 2.94e-04 | 279 | 315 | 14 | PS50082 |
| Domain | WD_REPEATS_REGION | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 KCTD3 SMU1 CSTF1 WDFY3 FBXW7 | 2.94e-04 | 279 | 315 | 14 | PS50294 |
| Domain | EGF-like_dom | SVEP1 MEP1A FAT1 FBN2 FAT4 ZAN CUBN TECTA PRF1 CNTNAP2 TENM1 LRP2 TNR | 3.30e-04 | 249 | 315 | 13 | IPR000742 |
| Domain | R3H | 3.70e-04 | 9 | 315 | 3 | SM00393 | |
| Domain | EGF_1 | SVEP1 MEP1A FAT1 FBN2 FAT4 ZAN FN1 CUBN PRF1 CNTNAP2 TENM1 LRP2 TNR | 4.14e-04 | 255 | 315 | 13 | PS00022 |
| Domain | fn3 | 4.36e-04 | 162 | 315 | 10 | PF00041 | |
| Domain | WD40_repeat_CS | 4.81e-04 | 164 | 315 | 10 | IPR019775 | |
| Domain | Cadherin_CS | 5.21e-04 | 109 | 315 | 8 | IPR020894 | |
| Domain | WD40_repeat_dom | IFT140 CFAP251 EDC4 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 KCTD3 SMU1 CSTF1 WDFY3 FBXW7 | 5.50e-04 | 297 | 315 | 14 | IPR017986 |
| Domain | EGF_2 | SVEP1 MEP1A FAT1 FBN2 FAT4 ZAN CUBN PRF1 CNTNAP2 TENM1 LRP2 TNR EPHA7 | 5.94e-04 | 265 | 315 | 13 | PS01186 |
| Domain | CADHERIN_1 | 6.62e-04 | 113 | 315 | 8 | PS00232 | |
| Domain | Cadherin | 6.62e-04 | 113 | 315 | 8 | PF00028 | |
| Domain | EGF | SVEP1 MEP1A FAT1 FBN2 FAT4 ZAN CUBN TECTA CNTNAP2 TENM1 LRP2 TNR | 6.75e-04 | 235 | 315 | 12 | SM00181 |
| Domain | EGF_3 | SVEP1 MEP1A FAT1 FBN2 FAT4 ZAN CUBN PRF1 CNTNAP2 TENM1 LRP2 TNR | 6.75e-04 | 235 | 315 | 12 | PS50026 |
| Domain | - | 7.02e-04 | 114 | 315 | 8 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 7.02e-04 | 114 | 315 | 8 | PS50268 | |
| Domain | R3H | 7.09e-04 | 11 | 315 | 3 | PS51061 | |
| Domain | R3H_dom | 7.09e-04 | 11 | 315 | 3 | IPR001374 | |
| Domain | R3H | 7.09e-04 | 11 | 315 | 3 | PF01424 | |
| Domain | - | 7.09e-04 | 11 | 315 | 3 | 3.30.1370.50 | |
| Domain | CA | 7.43e-04 | 115 | 315 | 8 | SM00112 | |
| Domain | Ephrin_rec_like | 7.59e-04 | 25 | 315 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 7.59e-04 | 25 | 315 | 4 | IPR011641 | |
| Domain | Cadherin-like | 7.87e-04 | 116 | 315 | 8 | IPR015919 | |
| Domain | ER_ret_rcpt | 8.41e-04 | 3 | 315 | 2 | IPR000133 | |
| Domain | TILa | 8.41e-04 | 3 | 315 | 2 | PF12714 | |
| Domain | TILa_dom | 8.41e-04 | 3 | 315 | 2 | IPR025615 | |
| Domain | ER_lumen_recept | 8.41e-04 | 3 | 315 | 2 | PF00810 | |
| Domain | ER_LUMEN_RECEPTOR_1 | 8.41e-04 | 3 | 315 | 2 | PS00951 | |
| Domain | ER_LUMEN_RECEPTOR_2 | 8.41e-04 | 3 | 315 | 2 | PS00952 | |
| Domain | IG | PRTG PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 IL1R2 PTPRS FGFR1 KALRN CD200R1 CSF1R LINGO1 CD80 | 8.51e-04 | 421 | 315 | 17 | SM00409 |
| Domain | Ig_sub | PRTG PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 IL1R2 PTPRS FGFR1 KALRN CD200R1 CSF1R LINGO1 CD80 | 8.51e-04 | 421 | 315 | 17 | IPR003599 |
| Domain | - | 1.13e-03 | 95 | 315 | 7 | 2.60.120.200 | |
| Domain | FN3 | 1.22e-03 | 185 | 315 | 10 | SM00060 | |
| Domain | EGF | 1.35e-03 | 126 | 315 | 8 | PF00008 | |
| Domain | VWF_A | 1.44e-03 | 99 | 315 | 7 | IPR002035 | |
| Domain | CH | 1.45e-03 | 73 | 315 | 6 | PS50021 | |
| Domain | - | 1.45e-03 | 73 | 315 | 6 | 2.60.120.260 | |
| Domain | Ig_2 | 1.45e-03 | 73 | 315 | 6 | PF13895 | |
| Domain | Gelsolin | 1.51e-03 | 14 | 315 | 3 | PF00626 | |
| Domain | Gelsolin-like_dom | 1.51e-03 | 14 | 315 | 3 | IPR007123 | |
| Domain | TIL_dom | 1.51e-03 | 14 | 315 | 3 | IPR002919 | |
| Domain | WD40 | IFT140 CFAP251 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 SMU1 CSTF1 WDFY3 FBXW7 | 1.56e-03 | 259 | 315 | 12 | PF00400 |
| Domain | Dpy19 | 1.66e-03 | 4 | 315 | 2 | PF10034 | |
| Domain | Dpy-19/Dpy-19-like | 1.66e-03 | 4 | 315 | 2 | IPR018732 | |
| Domain | VDCC_a2/dsu | 1.66e-03 | 4 | 315 | 2 | IPR013680 | |
| Domain | SUZ | 1.66e-03 | 4 | 315 | 2 | IPR024771 | |
| Domain | SUZ | 1.66e-03 | 4 | 315 | 2 | PS51673 | |
| Domain | VGCC_alpha2 | 1.66e-03 | 4 | 315 | 2 | PF08473 | |
| Domain | CH-domain | 1.67e-03 | 75 | 315 | 6 | IPR001715 | |
| Domain | IG_LIKE | PRTG PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 IL1R2 PTPRS FGFR1 KALRN CD200R1 CD1C CSF1R LINGO1 CD80 | 1.79e-03 | 491 | 315 | 18 | PS50835 |
| Domain | FN3 | 2.09e-03 | 199 | 315 | 10 | PS50853 | |
| Domain | CBS | 2.26e-03 | 16 | 315 | 3 | SM00116 | |
| Domain | Ig-like_dom | PRTG PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 IL1RL2 LRIG2 IL1R2 PTPRS FGFR1 KALRN CD200R1 CD1C CSF1R LINGO1 CD80 | 2.33e-03 | 503 | 315 | 18 | IPR007110 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | INTU CACNA2D2 BLNK NCAM2 TSNAX ADGRV1 ERBIN RSU1 DOCK5 KMT2C PTPRS SEL1L3 MKLN1 KATNIP PISD BAIAP3 AGAP1 AGAP3 EHBP1 KDELR2 UBR2 COL5A1 OGT MAN2B2 DEPTOR NEDD4L RASA3 B3GALNT2 XIAP FRYL TECTA PPP2R3A THADA FAM13A KLF7 CLMN NAT10 NAXD DIP2C MACF1 GREB1 PNPLA7 VPS13B | 5.48e-11 | 1489 | 324 | 43 | 28611215 |
| Pubmed | USP34 ADGRV1 ERBIN KMT2C CLCN6 XPO5 BAIAP3 TTC28 SYNE1 ALPK1 CADPS DIP2C MACF1 POFUT1 WDFY3 SNRNP200 | 4.60e-10 | 225 | 324 | 16 | 12168954 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 DPY19L3 EMC1 GALNT1 ENPP1 ITGA3 MBOAT2 ITPR2 LRIG2 FAT1 FBN2 MGAT5 PTPRS SEL1L3 KDELR1 HSPA5 FAM8A1 QSOX2 UBR2 COL5A1 CACNA2D1 FAT4 MAN2B2 NEDD4L B3GALNT2 TMED7 SLC4A2 TGM2 THADA NDC1 SLC12A2 STRAP GUSB DPY19L4 CCT8 POFUT1 | 8.67e-10 | 1201 | 324 | 36 | 35696571 |
| Pubmed | USP34 ACACB SEC24A MCCC1 ERBIN RYR2 PHB1 LRIG2 DOCK5 FAT1 WIZ SEC24B EEF2K TASOR SEC23A AGAP1 AGAP3 FAT4 FN1 EFCAB6 TTC28 MUC16 PPP2R3A THADA NDC1 SLC12A2 CCT8 SNRNP200 | 1.42e-09 | 777 | 324 | 28 | 35844135 | |
| Pubmed | Ceacam1L Modulates STAT3 Signaling to Control the Proliferation of Glioblastoma-Initiating Cells. | 1.76e-09 | 14 | 324 | 6 | 26238781 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB3 USP34 DPY19L3 GALNT1 GCNT3 ACO1 ITGA3 PHB1 DOCK5 FAT1 XPO5 PTPRS KDELR1 PISD FGFR1 HSPA5 RAB5B FAM8A1 QSOX2 CLASP1 TMED7 UNC50 SLC4A2 TBC1D8 THADA NDC1 STRAP GUSB ABCB8 DPY19L4 MACF1 WDFY3 STX16 | 1.86e-09 | 1061 | 324 | 33 | 33845483 |
| Pubmed | A2M ZBTB6 PSG2 PSG3 PSG5 ERBIN SVEP1 RYR2 FBN2 XPO5 PPP1R37 HTATSF1 GPNMB EVC2 FN1 NEDD4L TGM2 PPP2R5E DCP1B MACF1 STX16 TNPO3 SMAD1 SMAD5 | 2.23e-09 | 591 | 324 | 24 | 15231748 | |
| Pubmed | 2.91e-09 | 15 | 324 | 6 | 30674283 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EMC1 ILK SEC24A MCCC1 EDC4 ERBIN STAT3 KIAA0753 SBF1 PIK3C2A SEC24B AGAP3 EHBP1 NEDD4L TTC28 CLASP1 MAP3K14 XIAP FRYL ALPK1 PTPN21 SLC12A2 FAM13A DCP1B CLMN MACF1 MAPK4 PLCH1 TNPO3 | 3.27e-09 | 861 | 324 | 29 | 36931259 |
| Pubmed | USP34 ZBTB6 GALNT1 SPG7 RAPGEF5 RPS6KA3 PSMB6 TSNAX PTCH1 ERBIN KIAA0753 KMT2C MKLN1 TASOR BAIAP3 PCDH18 QSOX2 CSTPP1 OGT FN1 TMED7 XIAP FRYL CUBN SMTN PPP2R5E CLMN NAT10 RBPJ LRP2 MACF1 VPS13B | 1.14e-08 | 1084 | 324 | 32 | 11544199 | |
| Pubmed | INTU RAPGEF5 CSMD3 ERBIN ADCY2 XPO5 SEL1L3 KATNIP BAIAP3 UBR2 NEDD4L TTC28 CLASP1 SYNE1 R3HDM2 PPP2R5E CADPS MACF1 VPS13B | 1.21e-08 | 407 | 324 | 19 | 12693553 | |
| Pubmed | ACACB ERBIN CYFIP1 SBF1 PPP1R37 CSTPP1 AGAP1 EHBP1 NEDD4L RASA3 COQ5 RALGAPA2 BLZF1 NDC1 SLC12A2 GUSB MACF1 PLCH1 STX16 | 2.08e-08 | 421 | 324 | 19 | 36976175 | |
| Pubmed | A2M POGLUT3 EMC1 ILK ITGA3 PHB1 LRIG2 FBN2 PTPRS SEL1L3 HSPA5 MAN2B2 B3GALNT2 COPS3 PRPF8 TGM2 STRAP SMC3 GUSB PRF1 CCT8 POFUT1 SNRNP200 | 2.11e-08 | 613 | 324 | 23 | 22268729 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 4.38e-08 | 77 | 324 | 9 | 16944957 | |
| Pubmed | PRTG PSG1 PSG2 PSG3 PSG5 PSG11 NCAM2 LRIG2 PTPRS KALRN CSF1R LINGO1 | 4.51e-08 | 162 | 324 | 12 | 25826454 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 8.24e-08 | 13 | 324 | 5 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 8.24e-08 | 13 | 324 | 5 | 19273835 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 20044046 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 32150576 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 8.24e-08 | 13 | 324 | 5 | 12832451 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 25406283 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 8380065 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 1279194 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 25724769 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 8.24e-08 | 13 | 324 | 5 | 22092845 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 8.24e-08 | 13 | 324 | 5 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 8.24e-08 | 13 | 324 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 8.24e-08 | 13 | 324 | 5 | 23800882 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 8.24e-08 | 13 | 324 | 5 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 8.24e-08 | 13 | 324 | 5 | 39168268 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 8402684 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 8.24e-08 | 13 | 324 | 5 | 21949477 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 26219866 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 2133556 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 8.24e-08 | 13 | 324 | 5 | 19358828 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 8.24e-08 | 13 | 324 | 5 | 34058224 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 8.24e-08 | 13 | 324 | 5 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 8.24e-08 | 13 | 324 | 5 | 25972571 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 8.24e-08 | 13 | 324 | 5 | 15220458 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 18843289 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 15207636 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 21081647 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 11133662 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 11483763 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 18003729 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 8.24e-08 | 13 | 324 | 5 | 27695943 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 8.24e-08 | 13 | 324 | 5 | 16638824 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 8.24e-08 | 13 | 324 | 5 | 21670291 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 22162753 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 2702644 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 11801635 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 21760897 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 1719235 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 16619040 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 8.24e-08 | 13 | 324 | 5 | 8209741 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 32521208 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 8.24e-08 | 13 | 324 | 5 | 29967450 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 1653760 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 32169849 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 8.24e-08 | 13 | 324 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 8.24e-08 | 13 | 324 | 5 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 8.24e-08 | 13 | 324 | 5 | 15316023 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 15331748 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 8.24e-08 | 13 | 324 | 5 | 22406619 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 7628460 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 19008452 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 2164599 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 29396368 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 8.24e-08 | 13 | 324 | 5 | 33352461 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 38381498 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 1633107 | ||
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 8.24e-08 | 13 | 324 | 5 | 32027621 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 8.24e-08 | 13 | 324 | 5 | 27777319 | |
| Pubmed | 8.24e-08 | 13 | 324 | 5 | 18848945 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.09e-07 | 6 | 324 | 4 | 25966694 | |
| Pubmed | 1.09e-07 | 6 | 324 | 4 | 20519450 | ||
| Pubmed | 1.09e-07 | 6 | 324 | 4 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.09e-07 | 6 | 324 | 4 | 16844763 | |
| Pubmed | 1.27e-07 | 14 | 324 | 5 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.27e-07 | 14 | 324 | 5 | 34666041 | |
| Pubmed | 1.27e-07 | 14 | 324 | 5 | 34619794 | ||
| Interaction | PTCH1 interactions | SPG7 CACNA2D2 ENPP1 PTCH1 STAT3 PHB1 MGAT5 PXYLP1 HSPA5 CACNA2D1 NEDD4L NDST2 CD200R1 CNNM1 STRAP PRF1 | 7.66e-06 | 273 | 318 | 16 | int:PTCH1 |
| Interaction | ALKAL2 interactions | 1.84e-05 | 11 | 318 | 4 | int:ALKAL2 | |
| Interaction | LPA interactions | 1.84e-05 | 11 | 318 | 4 | int:LPA | |
| Interaction | LLCFC1 interactions | POGLUT3 CACNA2D2 ENPP1 FAT1 MGAT5 SEL1L3 FGFR1 CACNA2D1 FAT4 PLCH1 | 2.24e-05 | 121 | 318 | 10 | int:LLCFC1 |
| Interaction | UCN3 interactions | 2.53e-05 | 23 | 318 | 5 | int:UCN3 | |
| Interaction | OPALIN interactions | DOCK5 SBF1 XPO5 KDELR1 KDELR2 XPO4 SLC4A2 THADA NDC1 WDFY3 TNPO3 SMAD5 PIGM | 2.95e-05 | 209 | 318 | 13 | int:OPALIN |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 1.17e-04 | 153 | 325 | 7 | chr2q11 | |
| Cytoband | 2q11.2 | 1.64e-04 | 72 | 325 | 5 | 2q11.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.11e-07 | 11 | 220 | 5 | 1315 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.78e-06 | 3 | 220 | 3 | 287 | |
| GeneFamily | Fibronectin type III domain containing | 4.28e-06 | 160 | 220 | 11 | 555 | |
| GeneFamily | Cadherin related | 4.48e-05 | 17 | 220 | 4 | 24 | |
| GeneFamily | WD repeat domain containing | IFT140 CFAP251 CDC40 IFT80 WDR17 STRAP DCAF10 DAW1 SMU1 CSTF1 WDFY3 FBXW7 | 9.19e-05 | 262 | 220 | 12 | 362 |
| GeneFamily | HRAS like suppressor family | 1.44e-03 | 5 | 220 | 2 | 1227 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 DOK5 GALNT1 CENPE SEC24A RPS6KA3 MBOAT2 FAT1 MGAT5 PIK3C2A SEC24B MKLN1 TASOR AGAP1 EHBP1 UBR2 OGT TTC28 CLASP1 KLF6 MAP3K14 TOPBP1 SEMA5A R3HDM2 FRYL TRAPPC8 PPP2R3A PPP2R5E KLF7 SMC3 RBPJ MACF1 WDFY3 VPS13B | 2.72e-09 | 856 | 325 | 34 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CENPE SEC24A FAT1 MGAT5 SEC24B MKLN1 TASOR AGAP1 EHBP1 UBR2 OGT CLASP1 KLF6 TOPBP1 SEMA5A R3HDM2 FRYL TRAPPC8 PPP2R3A PPP2R5E KLF7 RBPJ | 1.06e-07 | 466 | 325 | 22 | M13522 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | TPP2 PSG1 PSG2 PSG3 PSG5 PSG11 RPS6KA3 FN1 TGM2 GUSB DUSP16 SNTB2 | 3.13e-06 | 182 | 325 | 12 | MM993 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 4.16e-06 | 35 | 325 | 6 | MM757 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | IFT140 RSAD1 ACACB EDC4 OSBPL7 IFT80 OGT HELQ SMTN CLMN MACF1 | 7.70e-06 | 166 | 325 | 11 | M6826 |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | ELMOD2 TINAG SAG IL1R2 SEL1L3 TRHDE NDST2 SEMA5A CUBN RALGAPA2 DAW1 DUSP16 | 8.25e-06 | 200 | 325 | 12 | M7417 |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | TPP2 GALNT1 SEC24A BLNK TSNAX RSU1 CDC40 VNN2 SEC24B SEL1L3 TASOR HSPA5 FAM8A1 SEC23A UBR2 OGT KALRN TOPBP1 FCN3 TGM2 STRAP SNRNP200 RBM34 SMAD1 | 9.17e-06 | 705 | 325 | 24 | M1410 |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | INTU CFAP251 ENPP1 SEC24A BLNK CPED1 MBOAT2 KDELR1 KDELR2 EVC2 TG TGM2 GUSB DUSP16 | 1.58e-05 | 287 | 325 | 14 | M6510 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TPP2 SPG7 ENPP1 SPEF2 ITPR2 SAG MGAT5 IFT80 CMAHP TMEM64 KLF6 RASA3 MAP3K8 XPO4 CD200R1 TG THADA CADPS MACF1 | 1.71e-05 | 498 | 325 | 19 | M1741 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | NDE1 MBOAT2 KIAA0753 DOCK5 KMT2C FAT1 OSBPL7 PISD GPNMB HSPA5 AGAP3 NEDD4L KLF6 B3GALNT2 MAP3K14 ABCB6 PTPN21 BLZF1 TFAP2C SLC4A2 TGM2 THADA KLF7 RBPJ WDFY3 SMAD1 | 2.16e-05 | 843 | 325 | 26 | M2356 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TPP2 SPG7 ENPP1 SPEF2 ITPR2 SAG MGAT5 IFT80 CMAHP TMEM64 KLF6 RASA3 MAP3K8 XPO4 CD200R1 TG THADA CADPS MACF1 | 2.19e-05 | 507 | 325 | 19 | MM1030 |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | INTU CFAP251 ENPP1 SEC24A BLNK CPED1 MBOAT2 KDELR1 KDELR2 EVC2 TG TGM2 GUSB DUSP16 | 2.31e-05 | 297 | 325 | 14 | MM1003 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 2.75e-05 | 48 | 325 | 6 | MM531 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | A2M DOK5 ATP8B4 EMC1 ACACB TRPC4 GFPT1 SEL1L3 GPNMB FN1 KLF6 MAP3K8 ANKRD36B TGM2 FAM13A CLMN TENM1 | 2.79e-05 | 427 | 325 | 17 | M17923 |
| Coexpression | BASSO_CD40_SIGNALING_DN | 2.85e-05 | 71 | 325 | 7 | M1899 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | ABCA4 SPG7 ACACB PSG3 ENPP1 PSG11 ITGA3 SVEP1 CDC40 FGFR1 RAB5B MAN2B2 FN1 ABCB6 PTPN21 CUBN PPP2R3A ROS1 | 3.76e-05 | 482 | 325 | 18 | M12144 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.35e-05 | 32 | 325 | 5 | MM2 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | EMC1 ITGA3 CLCN6 PTPRS FGFR1 HSPA5 RAB5B COL5A1 OGT FN1 NEDD4L KLF6 TMED7 ZNF561 POFUT1 PNPLA7 PIGM | 9.09e-05 | 470 | 325 | 17 | MM1053 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | IL1RL2 MBOAT2 ADCY2 FREM1 RYR2 ITPR2 LRIG2 FBN2 ADAMTS17 PCDH18 FAT4 MUC16 ALPK1 CRABP1 ACE2 PLXNA4 EPHA7 | 3.03e-05 | 357 | 318 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | PRTG PGM2L1 CPED1 FREM1 FBN2 SEL1L3 ADAMTS17 FGFR1 CACNA2D1 TTC28 CECR2 PLCH1 | 3.83e-05 | 194 | 318 | 12 | gudmap_kidney_P0_CapMes_Crym_k2_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | NCAM2 PGM2L1 GFPT1 RYR2 MKLN1 CACNA2D1 CLASP1 XIAP SEMA5A SMAD5 EPHA7 | 4.07e-05 | 165 | 318 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | FREM1 RYR2 ITPR2 FBN2 PCDH18 MUC16 ALPK1 CRABP1 PLXNA4 EPHA7 | 4.22e-05 | 137 | 318 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | POGLUT3 ENPP1 IL1RL2 MBOAT2 ADCY2 PDCD4 SVEP1 FREM1 RYR2 ITPR2 LRIG2 FBN2 ADAMTS17 PCDH18 CACNA2D1 FAT4 OGT RASA3 MUC16 ALPK1 CRABP1 ACE2 PLXNA4 DIP2C SMAD5 EPHA7 | 5.52e-05 | 740 | 318 | 26 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA4 NCAM2 ADGRV1 CSMD3 FREM1 RYR2 RYR3 FAT1 FBN2 PTPRQ PKHD1 DISP3 TRHDE FAT4 ZAN EFCAB6 KALRN TENM1 LRP2 ROS1 PLCH1 HYDIN EPHA7 | 4.66e-23 | 184 | 325 | 24 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA4 NCAM2 ADGRV1 CSMD3 FREM1 RYR2 RYR3 FAT1 FBN2 PTPRQ PKHD1 DISP3 TRHDE FAT4 ZAN EFCAB6 KALRN TENM1 LRP2 ROS1 PLCH1 HYDIN EPHA7 | 4.66e-23 | 184 | 325 | 24 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M ABCA4 NCAM2 ADGRV1 CSMD3 FREM1 RYR2 RYR3 FAT1 FBN2 PTPRQ PKHD1 DISP3 TRHDE FAT4 ZAN EFCAB6 KALRN TENM1 LRP2 ROS1 PLCH1 HYDIN EPHA7 | 4.66e-23 | 184 | 325 | 24 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 ADCY2 SVEP1 FREM1 RYR2 RYR3 FBN2 PTPRQ PKHD1 WDR17 TRHDE CECR2 TEAD4 TECTA CNTNAP2 LRP2 HYDIN | 3.54e-15 | 160 | 325 | 17 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 ADCY2 SVEP1 FREM1 RYR2 RYR3 FBN2 PTPRQ PKHD1 WDR17 TRHDE CECR2 TEAD4 TECTA CNTNAP2 LRP2 HYDIN | 3.54e-15 | 160 | 325 | 17 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | NCAM2 CSMD3 ADCY2 SVEP1 FREM1 RYR2 TRHDE COL5A1 CACNA2D1 FAT4 FN1 TTC28 KALRN TGM2 CNTNAP2 | 1.57e-11 | 194 | 325 | 15 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 CSMD3 RYR2 RYR3 PKHD1 ZAN POLR2A CUBN CNTNAP2 PLXNA4 LRP2 DGKI PLCH1 HYDIN | 2.98e-11 | 169 | 325 | 14 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | RNLS FAT1 FBN2 SLC35F3 SEL1L3 PKHD1 TMEM64 TRHDE SH3TC2 SEMA5A CNNM1 WDFY3 HYDIN EPHA7 | 8.05e-11 | 182 | 325 | 14 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | USP34 ITPR2 KMT2C MGAT5 MKLN1 AGAP1 UBR2 TTC28 CLASP1 LINGO1 DIP2C WDFY3 VPS13B FBXW7 | 2.63e-10 | 199 | 325 | 14 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK2 BLNK ADGRV1 CSMD3 FREM1 RYR2 PTPRQ PKHD1 TRHDE CNTNAP2 LRP2 HYDIN GRAP | 5.91e-10 | 175 | 325 | 13 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA4 MKLN1 PKHD1 FGFR1 TRHDE DEPTOR SYNE1 PPP2R3A TENM1 DIP2C DGKI HYDIN EPHA7 | 1.25e-09 | 186 | 325 | 13 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA4 MKLN1 PKHD1 FGFR1 TRHDE DEPTOR EFCAB6 MAP3K14 PPP2R3A TENM1 DIP2C DGKI HYDIN | 1.34e-09 | 187 | 325 | 13 | c31130fc2f9f882944b2ba366a034a03f051c4b9 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA4 ADGRV1 MKLN1 PKHD1 FGFR1 TRHDE DEPTOR PPP2R3A TENM1 DIP2C DGKI HYDIN EPHA7 | 1.43e-09 | 188 | 325 | 13 | af740fa78542438fdff627ea1f74f4eee43316be |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | ILK CPED1 ADCY2 PDCD4 SVEP1 FREM1 PTPRS ADAMTS17 PCDH18 COL5A1 CACNA2D1 FN1 MACF1 | 1.52e-09 | 189 | 325 | 13 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | A2M NCAM2 SVEP1 FREM1 RYR2 PTPRS TRHDE COL5A1 CACNA2D1 FAT4 FN1 TTC28 CNTNAP2 | 1.96e-09 | 193 | 325 | 13 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | A2M TRPC4 NCAM2 SVEP1 RYR2 PTPRS ADAMTS17 TRHDE COL5A1 FN1 TTC28 TGM2 PLXNA4 | 2.23e-09 | 195 | 325 | 13 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PTCH1 SVEP1 FREM1 RYR2 ADAMTS17 PZP COL5A1 FN1 SYNE1 SEMA5A TGM2 PLXNA4 MACF1 | 2.85e-09 | 199 | 325 | 13 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ENPP1 FAT1 FBN2 SEL1L3 PKHD1 TMEM64 TRHDE COL5A1 CNNM1 LRP2 HYDIN EPHA7 | 9.87e-09 | 181 | 325 | 12 | 6956ecd6264f7469a25e555673bce4eb97d28f7a |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | TINAG FAT1 PKHD1 TRHDE CUBN ACE2 CNNM1 PPP2R3A TENM1 LRP2 HYDIN EPHA7 | 1.12e-08 | 183 | 325 | 12 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FAT1 FBN2 SLC35F3 SEL1L3 PKHD1 TMEM64 TRHDE SH3TC2 CNNM1 WDFY3 HYDIN EPHA7 | 1.34e-08 | 186 | 325 | 12 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | A2M ATP8B4 ANKRD36C ITPR2 LRIG2 IFT80 HSPA5 UBR2 CLASP1 FRYL NDC1 MACF1 | 1.34e-08 | 186 | 325 | 12 | 8571956890fc9894d766ba294a28e376b4aba428 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ADCY2 TINAG FAT1 SLC35F3 SEL1L3 PKHD1 SEMA5A CUBN LRP2 PLCH1 HYDIN EPHA7 | 1.34e-08 | 186 | 325 | 12 | f28d72b47624b69a580b4429e2be560a26898591 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PRTG CACNA2D2 RAPGEF5 MCCC1 ADGRV1 NEDD4L SYNE1 CECR2 MBIP LRP2 ROS1 PLCH1 | 2.02e-08 | 193 | 325 | 12 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PRTG CACNA2D2 RAPGEF5 MCCC1 ADGRV1 NEDD4L SYNE1 CECR2 MBIP LRP2 ROS1 PLCH1 | 2.02e-08 | 193 | 325 | 12 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | A2M NCAM2 SVEP1 FREM1 RYR2 PTPRS ADAMTS17 TRHDE COL5A1 CACNA2D1 FN1 MACF1 | 2.02e-08 | 193 | 325 | 12 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CPED1 SVEP1 FREM1 RYR2 PTPRS PZP TRHDE COL5A1 FN1 SYNE1 SEMA5A PLXNA4 | 2.14e-08 | 194 | 325 | 12 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M DCDC2C NCAM2 CPED1 SVEP1 KCNN3 TRHDE COL5A1 FAT4 FN1 SYNE1 CRABP1 | 2.54e-08 | 197 | 325 | 12 | 0dd71e399f253787fa546a7e90c5373180b89ffd |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PCSK2 PRTG CACNA2D2 RAPGEF5 MCCC1 ADGRV1 NEDD4L CECR2 MBIP LRP2 ROS1 PLCH1 | 2.68e-08 | 198 | 325 | 12 | f948391296c261c473d339069a6d0f20ccd6f38f |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PTCH1 CPED1 SVEP1 FREM1 PZP PCDH18 COL5A1 FN1 SYNE1 SEMA5A TGM2 MACF1 | 2.84e-08 | 199 | 325 | 12 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PTCH1 SVEP1 FREM1 PZP TRHDE COL5A1 FN1 SYNE1 SEMA5A ALPK1 PLXNA4 MACF1 | 3.00e-08 | 200 | 325 | 12 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | PRTG CACNA2D2 TRPC4 CPED1 FBN2 ADAMTS17 LCN9 GPC5 CNTNAP2 TENM1 PLCH1 KCNAB3 | 3.00e-08 | 200 | 325 | 12 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | PRTG CACNA2D2 TRPC4 CPED1 FBN2 ADAMTS17 LCN9 GPC5 CNTNAP2 TENM1 PLCH1 KCNAB3 | 3.00e-08 | 200 | 325 | 12 | 97a010a1b6d551239cf6ea5a43319fb413ff180e |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | PRTG CACNA2D2 TRPC4 CPED1 FBN2 ADAMTS17 LCN9 GPC5 CNTNAP2 TENM1 PLCH1 KCNAB3 | 3.00e-08 | 200 | 325 | 12 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M TRPC4 NCAM2 SVEP1 FREM1 RYR2 PTPRS ADAMTS17 TRHDE COL5A1 FN1 TGM2 | 3.00e-08 | 200 | 325 | 12 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M NCAM2 CPED1 SVEP1 FREM1 RYR2 KCNN3 TRHDE COL5A1 FAT4 SYNE1 TENM1 | 3.00e-08 | 200 | 325 | 12 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | PTCH1 CPED1 SVEP1 FREM1 PZP PCDH18 TRHDE COL5A1 FN1 SYNE1 TGM2 MACF1 | 3.00e-08 | 200 | 325 | 12 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ADCY10 PRTG ADGRV1 CSMD3 PTPRQ PKHD1 ZAN TECTA TENM1 ROS1 HYDIN | 3.20e-08 | 162 | 325 | 11 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | A2M PRTG TRPC4 PTCH1 CSMD3 TBC1D16 FNDC1 FBN2 PCDH18 SEMA5A GREB1 | 6.67e-08 | 174 | 325 | 11 | f90ca117b729436cf452e2ddcec26ba525c5c13b |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FAT1 FBN2 SLC35F3 SEL1L3 PKHD1 TRHDE COL5A1 SYNE1 WDFY3 HYDIN EPHA7 | 7.49e-08 | 176 | 325 | 11 | 327a3e81b724252e36d786de92a3ffd721ea6d7b |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ARPP21 TINAG FAT1 SLC35F3 SEL1L3 TMEM64 SEMA5A CUBN LRP2 GREB1 EPHA7 | 8.90e-08 | 179 | 325 | 11 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | PRTG ABCA4 GCNT3 NEK10 MKLN1 PXYLP1 PGGHG CNNM1 TGM2 LINGO1 PLXNA4 | 9.42e-08 | 180 | 325 | 11 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | DCHS2 RAPGEF5 TRPC4 MROH5 RYR1 RYR3 ZDBF2 RALGAPA2 SLC6A7 HYDIN | 1.10e-07 | 144 | 325 | 10 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | PRTG CACNA2D2 RAPGEF5 ADGRV1 GPC5 TMEM64 NEDD4L CECR2 MBIP ROS1 PLCH1 | 1.11e-07 | 183 | 325 | 11 | 6847c1252d6bb105524f812658112517fd351eab |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA4 FAT1 FBN2 SEL1L3 PKHD1 TRHDE DEPTOR CNNM1 WDFY3 HYDIN EPHA7 | 1.11e-07 | 183 | 325 | 11 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-07 | 145 | 325 | 10 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | TINAG FAT1 SEL1L3 PKHD1 SEMA5A CUBN ACE2 CNNM1 LRP2 HYDIN EPHA7 | 1.18e-07 | 184 | 325 | 11 | 51ed1ebfdef45149541917c66cbacad87072e51f |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | PCSK2 PRTG CACNA2D2 RAPGEF5 ADGRV1 GPC5 NEDD4L MBIP LRP2 ROS1 PLCH1 | 1.18e-07 | 184 | 325 | 11 | 369b82f793deab672204558ae4e112cfa5aa9ccc |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | ATP8B4 BLNK CPED1 RYR1 ITPR2 MGAT5 DEPTOR CD200R1 CSF1R RBPJ KBTBD12 | 1.24e-07 | 185 | 325 | 11 | 8207f9eff113eed429e961748c6b17d672a13b33 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PRTG CACNA2D2 TRPC4 CPED1 FBN2 ADAMTS17 LCN9 GPC5 TENM1 PLCH1 KCNAB3 | 1.24e-07 | 185 | 325 | 11 | f4ac62009c0ad3346e71b809e17727303c4df153 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TINAG SEL1L3 PKHD1 AGAP1 EHBP1 TTC28 SEMA5A PPP2R3A LRP2 HYDIN EPHA7 | 1.31e-07 | 186 | 325 | 11 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | A2M TRPC4 NCAM2 SVEP1 RYR2 PTPRS ADAMTS17 TRHDE COL5A1 FN1 MACF1 | 1.39e-07 | 187 | 325 | 11 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | A2M RAPGEF5 TRPC4 CPED1 RYR2 RYR3 FN1 KALRN B3GALNT2 SMTN MACF1 | 1.46e-07 | 188 | 325 | 11 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IFT140 RAPGEF5 ITGA3 MBOAT2 MKLN1 KALRN SYNE1 SLC12A2 KLF7 KCTD3 TNR | 1.54e-07 | 189 | 325 | 11 | b6b4da51bc7f2c13a2f940540fdc61027d084835 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ARPP21 RAPGEF5 RYR2 SLC35F3 CACNA2D1 KALRN SLC6A7 LINGO1 FAM13A DGKI FBXW7 | 1.54e-07 | 189 | 325 | 11 | a75226616340045b581d08429d2e123e041dee55 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | PRTG CACNA2D2 RAPGEF5 MCCC1 ADGRV1 NEDD4L CECR2 MBIP LRP2 ROS1 PLCH1 | 1.81e-07 | 192 | 325 | 11 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | DOK5 RPS6KA3 ITGA3 STAT3 SEL1L3 FGFR1 COL5A1 RASA3 MAP3K14 TEAD4 MACF1 | 1.81e-07 | 192 | 325 | 11 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PCSK2 ARPP21 RAPGEF5 RYR2 SLC35F3 KALRN SLC6A7 LINGO1 FAM13A DGKI FBXW7 | 1.81e-07 | 192 | 325 | 11 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | DCHS2 CACNA2D2 PSG5 ANKRD30B CSMD3 FMO6P PTPRQ PKHD1 ITIH6 ZAN EFCAB6 | 1.91e-07 | 193 | 325 | 11 | 315840bc48899f3a36d57b19197509de19716e3d |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | INTU ABCA4 FAT1 PKHD1 GPNMB COL5A1 PGGHG SYNE1 TFAP2C CNNM1 EPHA7 | 1.91e-07 | 193 | 325 | 11 | 0f2167eef8203a5659c8c72e4e77646003d64797 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | PRTG CACNA2D2 RAPGEF5 MCCC1 ADGRV1 TMEM64 CECR2 MBIP LRP2 ROS1 PLCH1 | 1.91e-07 | 193 | 325 | 11 | 738f4f0a9ddde2432b429ab46838e353b1790589 |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ARPP21 ANKRD30B ADGRV1 RYR3 FBN2 IL1R2 ITIH6 MUC16 GABBR2 PRKAG3 WDFY3 | 2.12e-07 | 195 | 325 | 11 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PCSK2 ARPP21 CSMD3 RYR2 CACNA2D1 NEDD4L KALRN GABBR2 LINGO1 DGKI FBXW7 | 2.12e-07 | 195 | 325 | 11 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ARPP21 ANKRD30B ADGRV1 RYR3 FBN2 IL1R2 ITIH6 MUC16 GABBR2 PRKAG3 WDFY3 | 2.12e-07 | 195 | 325 | 11 | d3755929ebbbf5e3afde44281e9056ddb614a291 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PCSK2 CSMD3 RYR2 SLC35F3 KALRN SYNE1 GABBR2 ANKRD36B CADPS CNTNAP2 DGKI | 2.23e-07 | 196 | 325 | 11 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | USP34 ANKRD36C STAT3 KMT2C OGT SYNE1 FRYL ZDBF2 TENM1 MACF1 SNRNP200 | 2.34e-07 | 197 | 325 | 11 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | A2M TRPC4 CPED1 SVEP1 FGFR1 COL5A1 FAT4 FN1 RASA3 KALRN SYNE1 | 2.34e-07 | 197 | 325 | 11 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PRTG CACNA2D2 RAPGEF5 MCCC1 ADGRV1 NEDD4L CECR2 MBIP LRP2 ROS1 PLCH1 | 2.47e-07 | 198 | 325 | 11 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DOK5 NCAM2 SVEP1 FREM1 RYR2 COL5A1 CACNA2D1 FAT4 FN1 TTC28 KALRN | 2.47e-07 | 198 | 325 | 11 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PTCH1 CPED1 FNDC1 FAT1 PZP PCDH18 FN1 SYNE1 SMTN PLXNA4 EPHA7 | 2.59e-07 | 199 | 325 | 11 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | A2M PRTG ENPP1 PTCH1 SVEP1 FAT1 FGFR1 PCDH18 COL5A1 FN1 SEMA5A | 2.59e-07 | 199 | 325 | 11 | bf138cc692df727e087d140c014149ee5da00d9d |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | A2M PRTG ENPP1 PTCH1 SVEP1 FAT1 FGFR1 PCDH18 COL5A1 FN1 SEMA5A | 2.59e-07 | 199 | 325 | 11 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | A2M USP34 ANKRD36C UBR2 OGT SYNE1 FRYL TENM1 MACF1 SNRNP200 VPS13B | 2.59e-07 | 199 | 325 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | A2M NCAM2 SVEP1 FREM1 RYR2 PTPRS COL5A1 CACNA2D1 FAT4 FN1 TTC28 | 2.59e-07 | 199 | 325 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M NCAM2 CPED1 SVEP1 FREM1 RYR2 PTPRS FGFR1 TRHDE COL5A1 FN1 | 2.73e-07 | 200 | 325 | 11 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | PCSK2 CSMD3 RYR2 SLC35F3 KALRN SYNE1 GABBR2 ANKRD36B CADPS CNTNAP2 DGKI | 2.73e-07 | 200 | 325 | 11 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M CPED1 SVEP1 FREM1 FGFR1 GPNMB TRHDE COL5A1 FAT4 SYNE1 TENM1 | 2.73e-07 | 200 | 325 | 11 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M TRPC4 NCAM2 CPED1 SVEP1 FREM1 RYR2 PTPRS TRHDE COL5A1 FN1 | 2.73e-07 | 200 | 325 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M ENPP1 CPED1 SVEP1 FREM1 FGFR1 GPC5 COL5A1 FAT4 FN1 SYNE1 | 2.73e-07 | 200 | 325 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | PTCH1 SVEP1 FREM1 RYR2 PZP PCDH18 COL5A1 TTC28 ALPK1 PLXNA4 MACF1 | 2.73e-07 | 200 | 325 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M TRPC4 NCAM2 SVEP1 FREM1 RYR2 PTPRS TRHDE COL5A1 FN1 TGM2 | 2.73e-07 | 200 | 325 | 11 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | PTCH1 CPED1 DOCK5 FNDC1 FAT1 PZP PCDH18 CACNA2D1 FAT4 PLXNA4 EPHA7 | 2.73e-07 | 200 | 325 | 11 | a799fc7bb83ad0524362cb5010df949741fb7bf3 |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-07 | 166 | 325 | 10 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | CACNA2D2 RAPGEF5 ADGRV1 GPC5 AGAP1 NEDD4L SYNE1 LRP2 ROS1 PLCH1 | 4.62e-07 | 168 | 325 | 10 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-07 | 169 | 325 | 10 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | PRTG ADGRV1 FAT1 SEL1L3 GPC5 AGAP1 NEDD4L CECR2 MBIP SLC12A2 | 5.16e-07 | 170 | 325 | 10 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RASGRP4 CDH23 PTCH1 MEFV SBF1 IL1R2 KATNIP CMAHP CECR2 DUSP16 | 5.16e-07 | 170 | 325 | 10 | f3d5678669dcaed1836014cea543758b7ccc6b46 |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | PCSK2 ARPP21 PGM2L1 CACNA2D1 NEDD4L KALRN SYNE1 R3HDM2 LINGO1 FBXW7 | 6.73e-07 | 175 | 325 | 10 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CFAP251 RNLS FBN2 SLC35F3 SEL1L3 TMEM64 TFAP2C CNNM1 HYDIN EPHA7 | 6.73e-07 | 175 | 325 | 10 | 284fdc7a9d303636a637041846850d19d114861a |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | PCSK2 ARPP21 PGM2L1 CACNA2D1 NEDD4L KALRN SYNE1 R3HDM2 LINGO1 FBXW7 | 6.73e-07 | 175 | 325 | 10 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ST6GALNAC1 EPHB3 CACNA2D2 ANKRD30B MBOAT2 GFPT1 IL1R2 NEDD4L SMTN SLC12A2 | 6.73e-07 | 175 | 325 | 10 | 019ea30ac55748463d7917abf3d3f0e804189bfd |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ST6GALNAC1 EPHB3 CACNA2D2 ANKRD30B MBOAT2 GFPT1 KATNIP NEDD4L SMTN SLC12A2 | 7.86e-07 | 178 | 325 | 10 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | CACNA2D2 RAPGEF5 ADGRV1 NEDD4L SYNE1 CECR2 MBIP LRP2 ROS1 PLCH1 | 8.70e-07 | 180 | 325 | 10 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PRTG CACNA2D2 TRPC4 CPED1 CKMT2 ADAMTS17 SMTN TENM1 PLCH1 KCNAB3 | 9.15e-07 | 181 | 325 | 10 | af92b8b7f455210dab502ef6964f3a0162180759 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PRTG CACNA2D2 TRPC4 CPED1 ADAMTS17 LCN9 GPC5 TENM1 PLCH1 KCNAB3 | 9.62e-07 | 182 | 325 | 10 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | FAT1 SEL1L3 PKHD1 TRHDE DEPTOR PGGHG CNNM1 WDFY3 HYDIN EPHA7 | 1.01e-06 | 183 | 325 | 10 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 183 | 325 | 10 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.01e-06 | 183 | 325 | 10 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 183 | 325 | 10 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | PRTG ATP8B4 SVEP1 FREM1 STAT3 ITPR2 CACNA2D1 FAT4 TTC28 GREB1 | 1.06e-06 | 184 | 325 | 10 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.23e-06 | 187 | 325 | 10 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| Computational | Neighborhood of EGFR | 3.32e-05 | 32 | 213 | 6 | GNF2_EGFR | |
| Drug | chloro-m-cresol | 5.83e-07 | 6 | 323 | 4 | CID000012008 | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | IFT140 ACACB SVEP1 WIZ PLAAT2 FGFR1 GPNMB BAIAP3 GPER1 KLF6 TGM2 PRF1 LRP2 WDFY3 | 7.74e-07 | 194 | 323 | 14 | 2789_UP |
| Drug | Azumoleno | 1.35e-06 | 7 | 323 | 4 | CID000056259 | |
| Drug | AC1L1IPV | 2.25e-06 | 43 | 323 | 7 | CID000004683 | |
| Drug | cis-diammineplatinum(II | 2.83e-06 | 3 | 323 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.83e-06 | 3 | 323 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 2.83e-06 | 3 | 323 | 3 | CID000127713 | |
| Drug | aminodantrolene | 2.83e-06 | 3 | 323 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 2.83e-06 | 3 | 323 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.83e-06 | 3 | 323 | 3 | CID005748312 | |
| Drug | LOPAC | 3.47e-06 | 30 | 323 | 6 | CID000062696 | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A | USP34 ACACB RAPGEF5 SEC24A PTPRS TTC28 PGGHG ALPK1 TGM2 CD80 PRF1 IGHMBP2 SNRNP200 | 4.89e-06 | 196 | 323 | 13 | 1495_UP |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A | DOK5 PDE6C ITPR2 SAG WIZ CLCN6 UROD GPER1 RASA3 GABBR2 MBIP CAPN10 CSF1R | 5.77e-06 | 199 | 323 | 13 | 5635_DN |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | DOK5 ZBTB6 WIZ SBF1 BAIAP3 NEDD4L TTC28 SEMA5A CAPN10 CD1C CSF1R KLF7 IGHMBP2 | 6.09e-06 | 200 | 323 | 13 | 7007_UP |
| Drug | indo-1/AM | 9.41e-06 | 21 | 323 | 5 | CID000123918 | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | EPHB3 USP34 CENPE ERBIN ITPR2 TASOR BLZF1 UNC50 SMTN IGHMBP2 WDFY3 ZMYM6 | 1.07e-05 | 180 | 323 | 12 | 2859_DN |
| Drug | MW 1 | PGM2L1 RYR1 RYR2 STAT3 RYR3 UROD CACNA2D1 XPO4 SMU1 SMAD1 SMAD5 | 1.09e-05 | 151 | 323 | 11 | CID000073965 |
| Drug | PCB74 | 1.12e-05 | 4 | 323 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 1.12e-05 | 4 | 323 | 3 | CID006444275 | |
| Drug | SC 38249 | 1.12e-05 | 4 | 323 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 1.12e-05 | 4 | 323 | 3 | CID000035682 | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | ACACB PDCD4 DOCK5 SBF1 HTATSF1 ARMH3 NEDD4L GPER1 PTPN21 ABCB8 DIP2C WDFY3 | 2.39e-05 | 195 | 323 | 12 | 2122_DN |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | PDE6C NDE1 CPED1 FGFR1 SYNE1 ALPK1 GABBR2 CNTNAP2 POFUT1 PLCH1 STX16 SMAD5 | 2.39e-05 | 195 | 323 | 12 | 2126_UP |
| Drug | IAA-94 | 2.45e-05 | 61 | 323 | 7 | CID000003667 | |
| Drug | Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | USP34 IFT140 EMC1 IL1RL2 WIZ FGFR1 PGGHG SETD4 ALPK1 PTPN21 POFUT1 RBM34 | 2.52e-05 | 196 | 323 | 12 | 1479_UP |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A | DOK5 ITPR2 OSBPL7 FGFR1 BAIAP3 PTPN21 CUBN GABBR2 CSF1R GREB1 KCNAB3 VPS13B | 2.52e-05 | 196 | 323 | 12 | 2263_UP |
| Drug | estradiol, USP; Down 200; 0.01uM; ssMCF7; HG-U133A | IFT140 EMC1 ILK TSNAX BIK HRG FGFR1 GPER1 CRABP1 TGM2 CSF1R KCNAB3 | 2.52e-05 | 196 | 323 | 12 | 373_DN |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | IFT140 ZBTB6 MBOAT2 CLCN6 CDC40 PPP1R37 FGFR1 BAIAP3 CAPN10 POFUT1 WDFY3 ZMYM6 | 2.52e-05 | 196 | 323 | 12 | 2314_DN |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | PCSK2 MGAT5 VNN2 PLAAT2 FGFR1 TRHDE FN1 POLR2A GABBR2 SLC18A3 CD80 ABCB8 | 2.52e-05 | 196 | 323 | 12 | 5689_UP |
| Drug | lanthanum | CACNA2D2 TRPC4 CDH23 ADCY2 RYR1 RYR2 RYR3 CLCN6 CACNA2D1 MAPK4 | 2.52e-05 | 136 | 323 | 10 | CID000023926 |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | NDE1 ADCY2 RYR2 CLCN6 SBF1 UROD NEDD4L PGGHG MAP3K8 GABBR2 BLZF1 GREB1 | 2.65e-05 | 197 | 323 | 12 | 6061_DN |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A | EMC1 RYR2 WIZ CLCN6 PTPRS CNNM1 PPP2R3A PRF1 POFUT1 GREB1 WDFY3 SMAD5 | 2.65e-05 | 197 | 323 | 12 | 2301_DN |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | DOK5 RYR2 DOCK5 SBF1 FGFR1 TTC28 MAP3K14 TFAP2C SMTN CNNM1 GREB1 FBXW7 | 2.78e-05 | 198 | 323 | 12 | 6472_DN |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | USP34 ZBTB6 ACACB CACNA2D2 ADCY2 PDCD4 CKMT2 RASA3 ALPK1 CNTNAP2 GREB1 VPS13B | 2.78e-05 | 198 | 323 | 12 | 5595_UP |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | A2M CLCN6 FGFR1 TTC28 NDST2 PTPN21 GABBR2 CNNM1 ABCB8 CNTNAP2 POFUT1 WDFY3 | 2.78e-05 | 198 | 323 | 12 | 5445_DN |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | USP34 ADCY2 SAG IL1R2 FN1 NEDD4L SEMA5A ALPK1 TGM2 KLF7 CNTNAP2 STX16 | 2.93e-05 | 199 | 323 | 12 | 2866_UP |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | ACACB ENPP1 TBC1D16 HRG FGFR1 BAIAP3 NEDD4L KLF6 PCDHGA1 TENM1 TNPO3 SNTB2 | 2.93e-05 | 199 | 323 | 12 | 6186_UP |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | DOK5 PSG1 CACNA2D2 PSG11 CPED1 SAG VNN2 COL5A1 RASA3 GABBR2 BLZF1 POFUT1 | 2.93e-05 | 199 | 323 | 12 | 5644_DN |
| Drug | Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | SVEP1 CACNA2D1 FN1 GPER1 GABBR2 CAPN10 CNNM1 TGM2 LRP2 POFUT1 ZMYM6 RBM34 | 2.93e-05 | 199 | 323 | 12 | 3271_UP |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | NDE1 RYR2 SBF1 UROD SH3TC2 FAT4 SEMA5A GABBR2 FAM13A WDFY3 PLCH1 FBXW7 | 3.07e-05 | 200 | 323 | 12 | 5782_DN |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | EPHB3 EMC1 NDE1 ITPR2 WIZ CLCN6 SBF1 RASA3 PTPN21 CAPN10 TGM2 GREB1 | 3.07e-05 | 200 | 323 | 12 | 3276_DN |
| Drug | pyrachlostrobin | INTU POGLUT3 NDE1 CENPE ADGRV1 ITGA3 SVEP1 ITPR2 FAT1 FGFR1 GPC5 C1QTNF5 GPNMB COL5A1 MAN2B2 FN1 PGGHG PTPN21 TEAD4 SLC4A2 SLC6A7 TGM2 CSF1R GUSB DPY19L4 LRP2 PNPLA7 | 4.00e-05 | 811 | 323 | 27 | ctd:C513428 |
| Drug | lamotrigine | 4.20e-05 | 116 | 323 | 9 | CID000003878 | |
| Drug | FPL 64176 | 4.80e-05 | 15 | 323 | 4 | CID000003423 | |
| Drug | N-acetylhexosamine | A2M NCAM2 ITGA3 GFPT1 MGAT5 VNN2 UROD PZP RHCG OGT MAN2B2 FN1 FCN3 ACE2 CSF1R LINGO1 CD80 GUSB VPS13B | 5.01e-05 | 472 | 323 | 19 | CID000000899 |
| Drug | tiapamil | 5.48e-05 | 6 | 323 | 3 | CID000042106 | |
| Drug | MBED | 5.48e-05 | 6 | 323 | 3 | CID000129958 | |
| Drug | AC1O528X | 5.48e-05 | 6 | 323 | 3 | CID006475857 | |
| Drug | NSC114784 | 5.48e-05 | 6 | 323 | 3 | CID000419425 | |
| Drug | AC1L2AC7 | 5.50e-05 | 69 | 323 | 7 | CID000068733 | |
| Drug | Ret-P-Man | 6.32e-05 | 16 | 323 | 4 | CID006438377 | |
| Drug | M-HN | 6.99e-05 | 31 | 323 | 5 | CID000015450 | |
| Drug | bepridil | 8.02e-05 | 126 | 323 | 9 | CID000002351 | |
| Drug | ethosuximide | 8.64e-05 | 74 | 323 | 7 | CID000003291 | |
| Drug | isradipine | 9.03e-05 | 100 | 323 | 8 | CID000003784 | |
| Drug | NSC759576 | CACNA2D2 ADCY2 RYR1 RYR2 RYR3 CKMT2 PIK3C2A CACNA2D1 OGT ACE2 MITD1 | 9.47e-05 | 191 | 323 | 11 | CID000003075 |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 9.49e-05 | 7 | 323 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 9.49e-05 | 7 | 323 | 3 | CID003081001 | |
| Drug | CHEBI:564108 | 9.49e-05 | 7 | 323 | 3 | CID006400637 | |
| Drug | CNS 1145 | 9.54e-05 | 33 | 323 | 5 | CID000190902 | |
| Drug | IHC-64 | 9.54e-05 | 33 | 323 | 5 | CID000162753 | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | PCSK2 BLNK FGFR1 BAIAP3 COL5A1 ALPK1 TGM2 CSF1R KLF7 POFUT1 GREB1 | 1.04e-04 | 193 | 323 | 11 | 2829_UP |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A | CACNA2D2 CLCN6 RAB5B POLR2A ALPK1 PTPN21 SMTN CNNM1 CSF1R POFUT1 PLCH1 | 1.04e-04 | 193 | 323 | 11 | 6223_UP |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.04e-04 | 18 | 323 | 4 | CID000152226 | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | EMC1 ACACB PLAAT2 FGFR1 RAB5B CAPN10 SMTN GREB1 PLCH1 VPS13B FBXW7 | 1.09e-04 | 194 | 323 | 11 | 3194_DN |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | PSG11 GDAP1L1 FGFR1 COL5A1 GABBR2 TGM2 ABCB8 CNTNAP2 POFUT1 VPS13B SMAD1 | 1.14e-04 | 195 | 323 | 11 | 2317_UP |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | ADCY10 DCHS2 ACACB PSG5 IL1RL2 ADCY2 IL1R2 GPER1 SEMA5A TG POFUT1 | 1.14e-04 | 195 | 323 | 11 | 4162_UP |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | A2M IFT140 PDCD4 SAG FGFR1 PGGHG RASA3 CD1C POFUT1 PLCH1 VPS13B | 1.14e-04 | 195 | 323 | 11 | 3327_UP |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | RYR2 CLCN6 SBF1 FGFR1 COL5A1 FN1 GPER1 ALPK1 CRABP1 KLF7 LRP2 | 1.14e-04 | 195 | 323 | 11 | 5416_DN |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | USP34 SVEP1 ITPR2 HTATSF1 FN1 GPER1 TGM2 CSF1R PRF1 CNTNAP2 PLCH1 | 1.14e-04 | 195 | 323 | 11 | 3862_UP |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A | CACNA2D2 CPED1 WIZ PTPRS UROD BAIAP3 ALPK1 PTPN21 GABBR2 IGHMBP2 CNTNAP2 | 1.19e-04 | 196 | 323 | 11 | 4560_DN |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | USP34 IFT140 NDE1 BIK HTATSF1 COL5A1 TFAP2C PPP2R3A POFUT1 GREB1 STX16 | 1.19e-04 | 196 | 323 | 11 | 5984_DN |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | USP34 RNLS PSG1 SVEP1 FBN2 SBF1 FN1 RASA3 IGHMBP2 POFUT1 WDFY3 | 1.19e-04 | 196 | 323 | 11 | 2798_UP |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | IFT140 BIK DOCK5 WIZ COL5A1 FN1 SETD4 ALPK1 PPP2R3A CNTNAP2 GREB1 | 1.19e-04 | 196 | 323 | 11 | 5320_UP |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | EPHB3 ACACB PTCH1 CPED1 RYR2 WIZ FGFR1 MAP3K14 PTPN21 TEAD4 CNTNAP2 | 1.19e-04 | 196 | 323 | 11 | 4539_DN |
| Drug | Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A | TRAF6 ACACB RYR1 CLCN6 NDST2 ALPK1 SMTN KLF7 CNTNAP2 POFUT1 VPS13B | 1.19e-04 | 196 | 323 | 11 | 2888_DN |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.19e-04 | 196 | 323 | 11 | 3936_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | EMC1 DOCK5 WIZ FGFR1 BAIAP3 GPER1 ALPK1 PTPN21 LRP2 WDFY3 VPS13B | 1.25e-04 | 197 | 323 | 11 | 5436_DN |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; HL60; HT_HG-U133A | IFT140 EMC1 CACNA2D2 PSG11 RYR1 RYR3 DOCK5 HRG SMTN CD80 PRF1 | 1.25e-04 | 197 | 323 | 11 | 2191_UP |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | TRAF6 NDE1 RYR2 KIAA0753 SBF1 COL5A1 PTPN21 BLZF1 SMTN WDFY3 ZMYM6 | 1.25e-04 | 197 | 323 | 11 | 7223_DN |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A | C7orf25 OGT GPER1 SETD4 BLZF1 SMTN CNNM1 PPP2R3A CLMN SMAD5 FBXW7 | 1.25e-04 | 197 | 323 | 11 | 2629_DN |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | ZBTB6 EMC1 PPP1R37 RAB5B COL5A1 OGT RASA3 MBIP KLF7 POFUT1 WDFY3 | 1.25e-04 | 197 | 323 | 11 | 3363_DN |
| Drug | lariat | 1.27e-04 | 105 | 323 | 8 | CID000165706 | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | PTCH1 ITPR2 CLCN6 PPP1R37 GPNMB UROD NEDD4L KALRN SLC4A2 ACE2 LRP2 | 1.30e-04 | 198 | 323 | 11 | 6806_UP |
| Drug | Azaperone [1649-18-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | IL1R2 OSBPL7 PLAAT2 UROD KLF6 CAPN10 ACE2 CSF1R CD80 TENM1 LRP2 | 1.30e-04 | 198 | 323 | 11 | 5877_UP |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | WIZ GPNMB ALPK1 GABBR2 CRABP1 SMTN ABCB8 CNTNAP2 LRP2 WDFY3 PLCH1 | 1.30e-04 | 198 | 323 | 11 | 5451_DN |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | DCHS2 GCNT3 CACNA2D2 PDCD4 RYR1 PTPRS FGFR1 GPNMB FN1 TECTA CD1C | 1.30e-04 | 198 | 323 | 11 | 5053_UP |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A | A2M PDE6C RAPGEF5 TRPC4 IL1RL2 ADCY2 BAIAP3 KALRN GABBR2 ACE2 SNRNP200 | 1.30e-04 | 198 | 323 | 11 | 3713_UP |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; ssMCF7; HG-U133A | EMC1 ACACB PSG1 MAP3K14 SEMA5A CRABP1 TFAP2C TGM2 CSF1R GREB1 MAPK4 | 1.30e-04 | 198 | 323 | 11 | 376_DN |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | SBF1 IL1R2 MKLN1 BAIAP3 GPER1 KLF6 NDST2 SETD4 PTPN21 PPP2R3A FBXW7 | 1.30e-04 | 198 | 323 | 11 | 7023_UP |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | RYR1 LRIG2 WIZ HRG FGFR1 GPER1 POLR2A TG IGHMBP2 GREB1 VPS13B | 1.36e-04 | 199 | 323 | 11 | 6771_UP |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | EMC1 PDE6C SVEP1 OSBPL7 GPNMB NDST2 PTPN21 CSF1R CNTNAP2 POFUT1 KCNAB3 | 1.36e-04 | 199 | 323 | 11 | 5543_UP |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A | RYR2 DOCK5 WIZ PLAAT2 KLF6 MAP3K8 ALPK1 CSF1R CNTNAP2 WDFY3 PLCH1 | 1.36e-04 | 199 | 323 | 11 | 6093_DN |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | IFT140 EMC1 RNLS SVEP1 VNN2 PPP1R37 UROD BAIAP3 FN1 POFUT1 SNRNP200 | 1.36e-04 | 199 | 323 | 11 | 2787_UP |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | EMC1 CACNA2D2 WIZ FGFR1 KLF6 PTPN21 PRF1 POFUT1 WDFY3 STX16 VPS13B | 1.36e-04 | 199 | 323 | 11 | 3928_DN |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | IFT140 RYR2 CLCN6 PTPRS FGFR1 BAIAP3 CUBN GABBR2 BLZF1 TFAP2C LRP2 | 1.36e-04 | 199 | 323 | 11 | 5079_UP |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | EMC1 RYR2 FGFR1 ALPK1 GABBR2 CNNM1 LRP2 GREB1 PLCH1 STX16 RBM34 | 1.36e-04 | 199 | 323 | 11 | 5541_DN |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | PDE6C RAPGEF5 BLNK KLF6 ALPK1 PPP2R3A PRF1 ABCB8 ZMYM6 RBM34 SMAD5 | 1.36e-04 | 199 | 323 | 11 | 7516_UP |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | A2M CACNA2D2 PSG11 CPED1 FN1 NEDD4L GPER1 GABBR2 PRF1 LRP2 SNRNP200 | 1.42e-04 | 200 | 323 | 11 | 3866_UP |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | USP34 NDE1 PTPRS VNN2 FGFR1 CNNM1 PPP2R3A CSF1R IGHMBP2 CNTNAP2 ZMYM6 | 1.42e-04 | 200 | 323 | 11 | 6000_DN |
| Disease | Colorectal Carcinoma | PCSK2 ABCA4 CSMD3 KMT2C FAT1 GDAP1L1 FBN2 PTPRS PKHD1 GPNMB PZP EVC2 FN1 KALRN SYNE1 ABCB6 SETD4 CUBN CAPN10 SMTN TGM2 STRAP TENM1 LRP2 DIP2C SNRNP200 EPHA7 FBXW7 | 3.30e-09 | 702 | 317 | 28 | C0009402 |
| Disease | Malignant neoplasm of breast | CATSPERE ABCA4 RPS6KA3 TRPC4 PDCD4 STAT3 PHB1 HRG FGFR1 GPNMB EHBP1 FN1 GPER1 KALRN SYNE1 B3GALNT2 ABCB6 CUBN TRAPPC8 TECTA HELQ TGM2 CSF1R DAW1 ABCB8 TENM1 DIP2C CELA1 MACF1 VPS13B FBXW7 | 6.98e-07 | 1074 | 317 | 31 | C0006142 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.23e-06 | 3 | 317 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.23e-06 | 3 | 317 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 2.45e-05 | 54 | 317 | 6 | C0149925 | |
| Disease | cortical surface area measurement | EFCAB5 USP34 DCHS2 PRTG INTU RNLS PSG1 RAPGEF5 ADGRV1 PTCH1 CPED1 SVEP1 TBC1D16 FBN2 PKHD1 FGFR1 AGAP1 AGAP3 CACNA2D1 ZAN MAP3K14 SEMA5A FRYL TG THADA PPP2R5E FAM13A CADPS DGKI MACF1 SMAD5 EPHA7 | 2.46e-05 | 1345 | 317 | 32 | EFO_0010736 |
| Disease | FEV/FEC ratio | EFCAB5 USP34 DCHS2 ATP8B4 RNLS SPEF2 CDH23 PTCH1 ADCY2 PHB1 MGAT5 KCNN3 FGFR1 GPC5 AGAP3 DEPTOR PCDHGA1 R3HDM2 TEAD4 CRABP1 MBIP TFAP2C SMTN TG THADA FAM13A CADPS CNTNAP2 POFUT1 CAPZA3 | 2.74e-05 | 1228 | 317 | 30 | EFO_0004713 |
| Disease | retinitis pigmentosa (is_implicated_in) | 7.57e-05 | 41 | 317 | 5 | DOID:10584 (is_implicated_in) | |
| Disease | choroid plexus volume measurement | 9.83e-05 | 9 | 317 | 3 | EFO_0010293 | |
| Disease | transmembrane protein 119 measurement | 1.15e-04 | 2 | 317 | 2 | EFO_0803182 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVNHLRYGVSRSDQV | 116 | Q9NWW9 | |
| RIIITQQHFIYDISA | 611 | Q9UKU6 | |
| LRFVYETEHFNGVAE | 226 | Q16537 | |
| IYDNTEFTLAHGSVV | 416 | P21399 | |
| SHGIIQNEAEYLRVV | 106 | Q96KX2 | |
| ALVHRYLTGTYVQEE | 106 | Q96P47 | |
| YSFINIEHGQAVSLL | 1381 | Q96RT1 | |
| GVTSLNGIQFYERLH | 1126 | P04920 | |
| VFINTYRQATHLEDP | 536 | Q9P2K9 | |
| LQRIFDTYVGAQRTH | 31 | Q8IZ81 | |
| ALVHRYLTGTYVQEE | 86 | Q9UPQ3 | |
| VFAEDIHGITAERYA | 231 | Q9BXX2 | |
| VEGEAVHLARDFAYV | 306 | Q92754 | |
| YFETQDKHTGLVLVQ | 666 | Q5SY80 | |
| RSNNGFKIHYESVTV | 991 | Q7Z407 | |
| VQLFISTCNGEHIRY | 81 | Q9UNS2 | |
| VRVFTFSVGQHNYDV | 421 | Q9NY47 | |
| QHGYTVVIAEERLNA | 121 | A4D0V7 | |
| SQAVTDVYARFGEEH | 1851 | P78363 | |
| QVVGLYSRFDVIHLA | 391 | Q9UGI9 | |
| LSYLQQVFGTSLEEH | 166 | O94812 | |
| SVVIHTLAQEFDIYR | 131 | Q8WTX7 | |
| SVSQVERSLREGHYA | 31 | P0C5Y9 | |
| SVSQVERSLREGHYA | 31 | P0C5Z0 | |
| YGDQVQHFKVLREAS | 101 | Q13588 | |
| INRYGHFQATITIVE | 371 | Q14956 | |
| HYSIIKGNEERQFAI | 1246 | Q6V0I7 | |
| HGVFALYSDRQSILI | 4761 | Q8WXG9 | |
| DVYVERSTLVLHNIF | 141 | Q9Y5I7 | |
| QKGRIEFENVHFSYA | 586 | Q9NP58 | |
| ALYEAVHLNRNFITV | 301 | Q5T2E6 | |
| VTEAGHLQSLYTERL | 321 | Q9HC96 | |
| QHNIDVFSRDVYGKL | 206 | Q8N2N9 | |
| VTIYLGNRDYIDHVS | 26 | P10523 | |
| SLYVSVEVIRLGHSY | 341 | Q8TF62 | |
| EEVHALLRSFGTDYV | 621 | Q6ZPD9 | |
| RGAEQLVEILNYHIS | 66 | Q96PN6 | |
| GHNVSVEELAQTRIY | 51 | P33681 | |
| HSLGLAFIYDQTEDI | 86 | Q13323 | |
| IIDAVYQTGIHSAEF | 1391 | Q6DHV5 | |
| RQSFYHLVATVEDEG | 1596 | Q9H251 | |
| RDITPQTFHSYLEDI | 71 | Q9BXF3 | |
| RVAAYFGLDHNVDQT | 201 | Q9UBL0 | |
| QYHGAEAAQRFILTV | 246 | Q8TE56 | |
| QARAYIFIDEAHITQ | 1051 | P01023 | |
| YEFSNHRDVVVDLQG | 1166 | Q96QP1 | |
| LRNFIIGTSDAAVYH | 576 | Q8TBY9 | |
| SDTGYNLFLVATHEI | 196 | Q9NRE1 | |
| ALYNVDAGHRAVIFD | 26 | P35232 | |
| YTDSTGIDLHEFLVN | 146 | Q9Y2K5 | |
| AQARSYIFIDEAHIT | 1056 | P20742 | |
| GYVLFENTDSVHLAL | 331 | P42696 | |
| GSLRLNVVYTEDHVF | 281 | Q14644 | |
| RQYVDRVFHAITESG | 431 | Q14644 | |
| HEYQESTIGAAFLTQ | 46 | P61020 | |
| SLLDNRGSHYVAIVF | 201 | Q6ZRP7 | |
| HVEIRQDGDQFYIKT | 41 | P29762 | |
| FRLGTQEYLQQLESH | 1141 | Q6P2E9 | |
| TQAVADAVTYQLGFH | 86 | P28072 | |
| DAVTYQLGFHSIELN | 91 | P28072 | |
| DYVERTFTGEHVVAL | 116 | Q96MZ0 | |
| TFEVVHLARNLIYFG | 861 | Q14571 | |
| ETHGRHVEYLRFLQT | 1301 | Q14571 | |
| AIYALRIFDHEEVSQ | 526 | Q9HCL0 | |
| YELRHNQVESIFLSA | 1236 | O00763 | |
| LLQHNIDVFSRDVYG | 216 | Q5JPF3 | |
| GVRAFLQTYSHEVSL | 776 | Q9Y5G9 | |
| DAYVTFVRHSQDVLR | 1231 | Q9ULU8 | |
| IRHTVYAALQDFSQV | 476 | Q7L576 | |
| HFALEELAQAGYEVV | 266 | P06132 | |
| RLFAEYAANVTVHVI | 1856 | Q14517 | |
| ATFRLLGEVDHYQLA | 196 | O75636 | |
| HGVTQLGFYVLDRDS | 14171 | Q8WXI7 | |
| HGRNGVIDYTIFFTL | 186 | Q8WUE5 | |
| FSDLLHVRIPNSYEV | 4101 | Q8NEZ4 | |
| AHLDRVENTTVYYLV | 56 | P04196 | |
| FIEGRSYHITQSGEN | 201 | Q6ZWT7 | |
| VASVGDDLQYHFERL | 166 | Q9H2G9 | |
| AVIRTFVLVQHYAAA | 896 | Q4ZG55 | |
| TLRELTSQHPYAEVF | 556 | Q09328 | |
| LGIEVINTTDYLHFS | 231 | P78333 | |
| IGDFGLARIVDQHYS | 166 | P31152 | |
| RLEHLEQGFSVYVNG | 61 | O60303 | |
| LHRNSIQFTDGYEVK | 411 | P51812 | |
| RQEEIFYVGHSQGTT | 131 | Q5W064 | |
| NFRNGTETHTLALYE | 126 | Q8WX39 | |
| VRYGTVEDLLAFANH | 76 | P41279 | |
| LHVQISNESAIDFYR | 111 | Q9GZZ1 | |
| NLDVPHSYSVLERFV | 416 | Q53EL6 | |
| FNHLVVDERTGHIYL | 51 | Q9HCM2 | |
| EIFIDIGHYVRDISA | 466 | Q6ZWH5 | |
| LFGYSVALHRQTERQ | 51 | P26006 | |
| AYHTREVQLFVIDNG | 336 | Q9UGI6 | |
| VQFSTRYEHVLGALL | 1021 | O00443 | |
| FLIRHSQYHVDGSLE | 101 | Q96HS1 | |
| GTFAILHVRDVTTGY | 521 | Q6PCE3 | |
| SVGHANVLGYTLREF | 76 | Q8IXQ8 | |
| ISNYGTHFIRAVELG | 216 | P14222 | |
| EHDEYITETLTQFLG | 416 | P51160 | |
| RLAIHSQYEDFVVDG | 151 | Q6P474 | |
| VYLSTRTHGAVFNLE | 161 | Q5QP82 | |
| SGFVYFIVREVTDVH | 616 | O94915 | |
| FTVADLQAGVVRYHH | 471 | Q5H8C1 | |
| ETGELAQHLTYLEFR | 201 | Q8TDF6 | |
| ELFLQSHTEIGVSYQ | 331 | O60229 | |
| ELNTLEGHRNVVYAI | 126 | Q8N136 | |
| AVLTPNHVEFSRLYD | 201 | Q8IW45 | |
| AFRTVEDAGQYLHQK | 696 | Q86UK5 | |
| VQNTDFLLYVRVAHT | 181 | A0A1B0GTW7 | |
| LAHTRYTFEVQAVNG | 416 | P54753 | |
| SLEVGDNDLVYISHR | 171 | Q96FE5 | |
| DLQIRTVAITHDGYY | 116 | Q8TD46 | |
| FQTRDGEAIYQKVHS | 211 | Q9P104 | |
| DVEHITGLSFYQQRK | 891 | P22413 | |
| HTEEGRASIYQSVFT | 46 | O60774 | |
| SYSIFQELQLVHDTG | 6 | O75840 | |
| QELQLVHDTGYFSAL | 11 | O75840 | |
| NALHVDVDVSSGFIY | 2096 | P98164 | |
| VGSISFYNVTARSHI | 726 | O15553 | |
| DYQKTFRVVAGDHNL | 66 | Q9UNI1 | |
| VTNAYLGTRVFHDTL | 26 | Q32M88 | |
| LSTRGYVNFVNEVFH | 396 | Q2PPJ7 | |
| VEYLTQHGLTQEGLF | 66 | O94988 | |
| LAHANYTFEVEAVNG | 406 | Q15375 | |
| SSVVIDRRFEQAIHY | 16 | Q06190 | |
| YRTEAHQDVVGRFNE | 171 | Q9H0A0 | |
| QQEDTHRIVLYQADG | 791 | Q6ZV29 | |
| IILHFQISDIYISGE | 176 | Q9UPN3 | |
| DHTEVFRNSLGLIYA | 141 | O95248 | |
| HDFVDIYGLVAELRS | 2256 | Q9UMZ3 | |
| DQYSFIHEALLEAVG | 1636 | Q13332 | |
| GFLSYLEEIQSVRRH | 1076 | Q16825 | |
| DRDTGSHAEIIYNII | 2691 | Q6V1P9 | |
| LFDQAVYRVHLLETT | 241 | Q9Y5I3 | |
| YEFAVRLHVDQLSSP | 791 | Q2VWP7 | |
| RHAQNVTVDEVIGAY | 66 | O75864 | |
| HVEEDRNTNVYVSGL | 126 | O43719 | |
| ENTLFHYVALETVQG | 796 | Q9ULD6 | |
| VNIVEATEHFGYRNS | 136 | F5H284 | |
| REHNLYTVNITFLEV | 291 | Q9HB29 | |
| GSSIQLTIHDFDVEY | 1426 | O60494 | |
| IVDVASQVALYTFGH | 31 | Q8IZD4 | |
| RHYFSLGEIRNVETN | 426 | Q10472 | |
| HEIRFYQGVANVFST | 1136 | A4FU69 | |
| HTNVSILYADIVGFT | 286 | Q08462 | |
| GIITRHNLTYEFLQA | 846 | P51797 | |
| GFTIHRAKFIQSQDY | 161 | P07333 | |
| QVTGEHRSTVYISIF | 771 | Q4G0P3 | |
| QAERHFLLVDGSSIY | 381 | Q9P2H3 | |
| EEYFGSVAEIIRNHQ | 416 | Q8WV28 | |
| DRVLVNEQGHYDAVT | 126 | Q9BXJ0 | |
| DVRNDIYVTLIHGEF | 441 | Q9H7D0 | |
| QGTHILFREFSFVQA | 56 | Q9H6J7 | |
| YLFGLTREIQDHASQ | 91 | P29017 | |
| EIVHDTITRNLQAFY | 496 | Q5THR3 | |
| KVRVFTFSVGQHNYD | 381 | P54289 | |
| DLQDNHFYVAVGLET | 196 | A8MYV0 | |
| LHLRNVSFEDAGEYT | 326 | P11362 | |
| IRVNKISLQDYEGFH | 726 | O75912 | |
| LISIQQYGHQEVTRF | 681 | P02751 | |
| QYGHQEVTRFDFTTT | 686 | P02751 | |
| NLEEVVSVLHVFGYT | 81 | Q9BPX7 | |
| VYFVLLTAENHSGVS | 106 | Q4ZHG4 | |
| YDVVVGVLSARNNHE | 51 | Q8NCR0 | |
| IIQSEYGAETIAGFH | 536 | P08236 | |
| SRPFVEYNTSHILEA | 31 | Q9BY84 | |
| FVVSVNGLNVLHVDY | 371 | Q8TB45 | |
| TNRVYSLQFDGIHVV | 541 | Q969H0 | |
| NAYIVASRDFVQHVL | 296 | O95395 | |
| SLYNVLHEGTNFVVD | 276 | Q13418 | |
| SFERGVYELTHNNKT | 111 | Q7Z388 | |
| LTDANGERHDALYVV | 1426 | Q9Y2E4 | |
| DYSRGQLIEDVEHTF | 216 | Q9BYF1 | |
| YEETDILAQSLHRVF | 346 | Q9NX46 | |
| IQQLLFVSDHRAAYD | 221 | P20908 | |
| YQIRAHFSGQELNVV | 541 | Q8NDI1 | |
| AITGITFTILSYRHQ | 121 | Q96JA4 | |
| TLQGHAFEARIYAED | 376 | Q96RQ3 | |
| VRVTQEFLEYHVNGD | 611 | Q9Y2E5 | |
| YEIFRSLHTLVGQLD | 31 | Q9NS73 | |
| YVTIGELLDAHFQAR | 566 | Q6UXX5 | |
| DIYTIAFGIRNVTHI | 211 | Q5HYK3 | |
| QDFNYTDHTLGRIIL | 386 | O75899 | |
| IVSRGLDLNDVTHVY | 526 | Q86TM3 | |
| EGHTRLELYSQLFVG | 911 | Q9UHC6 | |
| VAHDGSATYLRFIIV | 106 | Q9Y547 | |
| FTFERSGHQLIVVDI | 261 | O00418 | |
| SVGYRALVQTEDHLL | 416 | Q8N766 | |
| YDGNHDTFRVEFLVV | 86 | P24390 | |
| EEEVQYNFHITKLGR | 821 | Q8TDG4 | |
| HIRYVISQGNDDSVF | 2831 | P35556 | |
| RTQAVFNHTEDYVLL | 356 | Q05048 | |
| SQHQARIEIESFYEG | 301 | P11021 | |
| NVTREDAGSYTLHII | 111 | Q9UQ72 | |
| RESEESIGTHYEFLQ | 466 | Q9P1V8 | |
| LFVLDVSHNAVEAGY | 681 | O95487 | |
| VRHVTTGQYLALTED | 281 | P21817 | |
| HQYDTGFDLDRVRTV | 1451 | Q92736 | |
| YDGNHDTFRVEFLVV | 86 | P33947 | |
| ESQEEVGQAVHFYTR | 1021 | Q96RY7 | |
| STIRIGDVYGFLVEH | 1371 | Q96RY7 | |
| RGVSINVLRHEAEFY | 86 | Q9Y597 | |
| VASYEEFRGIVLASH | 41 | Q8IW40 | |
| RVFHGNETTKNVYEE | 51 | Q02224 | |
| FQHNRTAYDIVAGTI | 391 | Q9UBU6 | |
| NVTREDAGSYTLHII | 111 | P11464 | |
| IDFKSNGHIYDNRIV | 721 | O15294 | |
| VLEDGILHYATTRQD | 71 | Q9BZF2 | |
| IEHYGEVLIRNTQDS | 651 | Q9BZF2 | |
| NVTREDAGSYTLHIV | 111 | Q16557 | |
| TAEFRELYALGSIHN | 371 | Q3ZCT8 | |
| TQGQFDEHYVLSSRV | 151 | P17540 | |
| FSVEEYLVHALQGSV | 331 | Q99558 | |
| HRVAQIFRLDSYTGE | 286 | Q9Y5H4 | |
| VAQVDLYILGQADHF | 336 | Q9H488 | |
| VYTAAREANAHEFIT | 581 | Q9NUT2 | |
| TIHDYFIDNPEISSR | 126 | Q6ZUA9 | |
| EDVLTVAYEHGVNLF | 111 | O43448 | |
| FQLGVSHVFEYIRSE | 226 | Q15404 | |
| RQYENHIFVGSKTAD | 276 | Q9NP92 | |
| RAVLREAGFHQYEVS | 261 | Q9HA92 | |
| YRALSVAVGTHVFQQ | 1646 | Q9C093 | |
| AFLVDVRHVSVYGSV | 406 | Q16572 | |
| GRIYTVYQLSHDIDV | 771 | Q6YHU6 | |
| VYQLSHDIDVGRFQT | 776 | Q6YHU6 | |
| HTLQGDQAYVETIRL | 646 | Q68CR1 | |
| EVTAGNRLFYHIVDS | 551 | Q9UQE7 | |
| TVVRYLFQTGSSHER | 1351 | Q8NF91 | |
| YHAGVATRQVLEELT | 396 | Q06210 | |
| RSAFYVLEQQHVGLA | 2121 | Q6P3W6 | |
| SAFYVLEQQHVGLAV | 2366 | Q6P3W6 | |
| AFYVLEQQHVGLAVD | 2611 | Q6P3W6 | |
| RSAFYVLEQQHVGLA | 3341 | Q6P3W6 | |
| HGYIQNLIIRDIFVD | 506 | Q96DL1 | |
| GVLLEVQYSSSIHDR | 181 | Q8WV92 | |
| GFSDVDHTYAQRTQL | 696 | Q9UL63 | |
| YLFVFDVSHNAVETG | 506 | O95486 | |
| QISTESFLHLRYQGT | 571 | O14841 | |
| TGELSEHQQYVIGLF | 46 | Q99527 | |
| VQEYDRHLGAVNTIV | 411 | O60508 | |
| EILHALGFYHEQSRT | 156 | Q16819 | |
| VSGLSEELRHYEAQQ | 1231 | Q13635 | |
| YVIDSQQALFELSHR | 561 | Q92565 | |
| DNQRLFLEYGFVSVH | 276 | Q9NVD3 | |
| QEIDSHDYVFRLSGA | 381 | Q9NSC7 | |
| FNIRYGTTVEEEKNH | 2631 | Q9UKZ4 | |
| LVYVEAFSQHAITGR | 136 | Q9BYL1 | |
| QARVYFEEAIHILNG | 546 | Q8TF17 | |
| EHSVRILYNGVDVTF | 416 | Q8TE99 | |
| VVNLHYGIRLVDSES | 241 | Q8IZU2 | |
| RVGVSYNVRHFISAE | 726 | O95785 | |
| QGVDLHIQYLTEVFS | 1186 | P08F94 | |
| FEQYLRIISHEAVGS | 906 | Q2KHM9 | |
| AFEVLRQHSTGDLQY | 16 | Q8N5J4 | |
| HTLNFEYAVERVLAG | 541 | Q9UQ90 | |
| EHTTGRIFESEVRYQ | 2216 | Q4LDE5 | |
| FAHEGQQYNITRSIE | 211 | P27930 | |
| DHYTSQIVFNGVRVI | 346 | Q8IY50 | |
| DTFFQILIYHGETIA | 651 | Q15436 | |
| HQNIYRDTFIVTLGN | 316 | Q99884 | |
| EILVITYGRSIAFHS | 196 | Q9Y3F4 | |
| LLAQSVNHGFEAVYE | 391 | Q99717 | |
| LLAQSVNHGFETVYE | 391 | Q15797 | |
| QGREALVHIIYLATD | 411 | Q13591 | |
| REFEDVVNILHSSYL | 121 | Q9UK61 | |
| TELYVQAVIFDHISR | 216 | Q6V702 | |
| FVLTENGERTYTVNH | 326 | Q96JQ2 | |
| EELAFGEVQITYLTH | 26 | Q9Y471 | |
| HNYFVSISELIGERD | 146 | Q9NQ89 | |
| AAINSLVEIYRHVGE | 186 | Q7Z460 | |
| VYEGDQRHNIVDILF | 466 | Q9NRU3 | |
| LVVDSHVQYRLGNVD | 556 | Q6P2Q9 | |
| VDVTVFGYSIVIHRA | 1161 | O75443 | |
| LTLHFEGRNYEASVD | 41 | P21980 | |
| FGDERGAIVHYTILN | 186 | Q7Z4H8 | |
| GTQDSFIAAVYEHAV | 21 | O95498 | |
| EFQEYGRAVTASSHL | 226 | Q8N587 | |
| FYVVHRAQVELNAAI | 326 | Q6YI46 | |
| HVILTDTFIGYLVGN | 181 | Q53HI1 | |
| YREVTLENFGHLASL | 71 | Q8N9K5 | |
| GERFQTVALERHQSY | 66 | Q08AN1 | |
| QVDYLAHFIEGLLNT | 316 | Q9C0E2 | |
| HADYLLRTGQVVDIS | 136 | P98170 | |
| FIFVNYSEGQTRAHL | 3346 | Q8IZQ1 | |
| ENTRVLYSLYGVVEH | 736 | Q9Y5T5 | |
| TATNHIGTRFQEYIL | 476 | O15394 | |
| FVNEATFTQDGHYII | 351 | Q2TAY7 | |
| ESGAEVYFRHRVTQI | 121 | Q5VYX0 | |
| HRVEAIVAFGDIYVS | 1821 | Q15413 | |
| LVEYFTQHGEVRTAF | 626 | P38935 | |
| NTLYHRGFTEDQLVL | 211 | O14662 | |
| VFHNLLGEIDQQYSR | 56 | P40763 | |
| VGSIRIYFDRDLHTN | 326 | Q9UG56 | |
| GHDITRLFYSNIQTV | 661 | P24928 | |
| FGDQSVEQIEHLRYK | 771 | O95759 | |
| SGYISEVRNFQETIH | 286 | Q9Y4K3 | |
| LFHDAFDIQYGVVVI | 906 | P55011 | |
| THVRFYQHLVSLGED | 586 | Q8TBP0 | |
| ENYVIVLTHFAVAGE | 981 | Q92752 | |
| VIDYQTHFRLREAQG | 161 | Q9Y3B3 | |
| LSDVNIDYTISFHGI | 741 | P29144 | |
| VSLDYNIIFHSVTGR | 916 | Q9HCK1 | |
| HRVLSDVDAFIAYVG | 686 | Q9HAV4 | |
| TLTDNTHGRYVLVIY | 126 | P52849 | |
| DVHQQIVYFSEGTLI | 331 | P08922 | |
| IAYVFEVSASEHGAQ | 411 | Q15561 | |
| HFVTLLRYGEGVSEQ | 121 | Q9HDD0 | |
| EASIFVHITINEIYG | 846 | Q4KWH8 | |
| QTVSTRYLHVEGGNF | 196 | Q06330 | |
| HFLQDRYIVVGVENL | 111 | Q9UBD6 | |
| TNDEVIHGIFKAYIQ | 356 | Q9Y5L0 | |
| VTELGRIASHYYITN | 981 | O75643 | |
| GTFERAVVYQEQHLS | 1051 | Q96AY4 | |
| FHRAITTGLQEYVEA | 116 | Q99598 | |
| TTGLQEYVEAVSFQH | 121 | Q99598 | |
| DTRFEVKYQNVVHGL | 201 | O95789 | |
| LNHGTSIREDILYVQ | 41 | Q96MP5 | |
| VENTQGHILYAFLVE | 226 | Q96MP5 | |
| SVDHAGTFIRTIQYR | 2691 | Q7Z7G8 | |
| DHINFTIGRQSYTLR | 601 | Q9Y2L5 | |
| DTHQRSFDIGIQIGY | 106 | Q14CZ0 | |
| NVTREDAGSYTLHII | 111 | P11465 | |
| ALYSHSAEVQVRLQF | 976 | Q70CQ2 | |
| LEAYFTRNHTVLQGT | 31 | Q9UJW2 | |
| EVRLTIHYENGFTIS | 456 | Q13425 | |
| VHLSEDVIARTYNIF | 181 | Q8IWV8 | |
| HFSGLEEAVYRNIQA | 21 | P50990 | |
| ALVFYGVFQDRTLHV | 31 | Q9H3S5 | |
| GVFQDRTLHVRYTDI | 36 | Q9H3S5 | |
| NVTREDAGSYTLHII | 111 | Q15238 | |
| YRDLNVSVTHLIAGE | 136 | Q92547 | |
| TYDQESHQVILRLGD | 1781 | P01266 | |
| AKTRGYEHVDIQNFS | 811 | P53814 | |
| SFNVYVGDALLHAIR | 91 | Q9UBN4 | |
| NFGLQVRYDGSHLVE | 1651 | Q9Y493 | |
| SIYINDTEFQGHKVI | 36 | Q15916 | |
| RVTLGYTQGFFETEH | 91 | P22310 | |
| QELQIVHETGYFSAL | 11 | Q99612 | |
| LDYSFRSIHVIQDLV | 16 | Q96E66 | |
| GEALEYTSILHLFNV | 556 | O94898 | |
| AIYRITTTFGEHLNA | 641 | Q9BTX1 | |
| KFEVQHSEGYRQISA | 81 | Q9NXR1 | |
| GKENFVRYLEHVQAV | 496 | P16519 | |
| DGRTFYIDHNSKITQ | 561 | Q96PU5 |